HDCN News Archive -- Clinical Pharmacology |
|
Oct23 |
Akebia sues CMS for denying coverage for Auryxia under Medicare Part D |
Oct23 |
Taking antihypertensives at bedtimes lowers cardiovascular risk. |
Aug14 |
Pretomanid, bedaquiline and linezolid combo FDA approved for resistant TB. |
Aug13 |
SPRINT substudy shows that intensive BP control lowers rate of white matter brain lesions. |
Jul02 |
HIV infection cured in mice using CRISPR technology. |
Jul01 |
Low grade E. Coli urinary tract infections picked up by DNA testing of urine. |
May09 |
Fournier gangrene of the genitals linked to SGLT2 inhibitor drugs |
Apr29 |
Immune cell test identifies patients with chronic fatigue syndrome. |
Apr06 |
Candida auris infections spreading rapidly across the globe. |
Apr03 |
Rehydrating with soft drinks after exercise increases AKI injury markers |
Jan24 |
Alzheimer disease linked to brain infection by gingivitis bacteria. |
Dec11 |
Randomized PIVOT trial published in NEJM suggests more IV iron is better. |
Dec05 |
Test detects presence of cancer in blood samples based on DNA methylation. |
Aug02 |
Bacteria becoming tolerant to high concentrations of alcohol in hand sanitizers. |
Apr28 |
CDC issues alert re warfarin coagulopathy and synthetic cannabinoids |
Feb28 |
In ICU, Ringer's lactate also better than saline. |
Feb28 |
Ringer's lactate causes less kidney injury than saline. |
Jan11 |
Lp(a) in the news in the New York Times |
Jan09 |
Inhibitors of NMMT reduce obesity by increasing fat cell metabolism. |
Sep05 |
Hypervirulent, carbipenem-resistant Klebsiella pneumonia outbreak in China. |
Aug11 |
NEJM: Idarucizumab effective for reversal of dabigatran effects. |
Aug10 |
Immunotherapy may arrest damage of beta cells in type 1 diabetes. |
Jun13 |
Can LIF be used to cure autoimmune diseases such as multiple sclerosis? and more? |
Jun06 |
Dr. Fred Coe's Kidney Stone Guide Book - a work in progress. |
Dec28 |
Pharmacies miss some drug interactions that are known to cause serious issues. |
Oct05 |
FDA warns about hepatitis B reactivation with direct acting hepatitis C antivirals. |
Jul28 |
Good Staph. in the nose makes novel peptide antibiotic that kills bad Staph. |
May29 |
Three days of fasting every 10 days improve autoimmune diseases (in mice). |
May29 |
Nicotinamide riboside protects mice from effects of diabetes. |
May24 |
CRIC study shows a high urinary sodium excretion in CKD linked to higher CV risk. |
May20 |
SPRINT shows lower than 120 BP systolic target in elderly results in improved outcomes |
Apr27 |
Tetraspanin-7 as an antibody target for type 1 diabete |
Apr13 |
New bacteria called Elizabethkingia affecting Midwest patients. |
Mar30 |
AC6 gene therapy improves cardiac function in patients with heart failure. |
Mar09 |
Desensitization procedure allows kidney transplants from any (living) donor. |
Mar09 |
Is the FDA allowing promotion of off-label uses of drugs as free speech? |
Feb29 |
Phage Therapy 2016 World Congress meets this June in Paris. |
Feb29 |
When will be see phage therapy for exit site and access infections? |
Feb27 |
Treatment of BP below 140 systolic in persons with diabetes may be counterproductive. |
Feb20 |
New blood-based tuberculosis test shows promising results. |
Feb14 |
Beetroot juice lowers blood pressure. |
Feb14 |
Second salty taste receptor more fully characterized in humans. |
Dec29 |
Myostatin antibody may prevent age-related decline in muscle mass. |
Dec29 |
Interleukin-17A may prevent and even reverse diabetic kidney injury. |
Dec26 |
Antibiotic-resistant bacteria frequency increases in U.S. streams and rivers |
Dec26 |
FGF21 suppresses cravings for sweets. |
Dec21 |
Ergocalciferol supplementation does not affect ESA dose in dialysis patients. |
Dec14 |
Even more news on the new HDCN Facebook page! |
Dec14 |
A bright future is predicted for renal denervation devices. |
Dec14 |
Primary aldo screening for resistant hypertension cost effective? |
Dec14 |
Some drugs cause weight gain by alterations in the gut microbiome. |
Dec12 |
Suicide gene therapy for prostate cancer |
Dec01 |
SecA inhibitors particularly effective against MRSA and other bacteria. |
Nov30 |
Multinucleated giant cells and amyloidosis |
Nov21 |
Orphan drug designation may lead to high drug prices, like for rituximab. |
Nov10 |
STHLM3 test for prostate cancer will be in Sweden by March of 2016. |
Nov10 |
L-DOPA may delay onset of age-related macular degeneration by 8 years. |
Nov10 |
Sprint Blood Pressure Trial article link at NEJM |
Nov10 |
Sprint study presented at the AHA Scientific Sessions and published in NEJM. |
Sep25 |
Giving BP meds at bedtime particularly effective in lowering diabetes risk |
Sep17 |
Empagliflozin use in diabetes associated with large reduction in CV risk. |
Sep11 |
SPRINT RCT data support an even lower BP target (120 systolic) for the elderly. |
Sep04 |
Hedge fund quant proposes a disease-specific false-positive rate to FDA for drug approval. |
Aug31 |
Spanish style mid-day "siestas" linked to lower blood pressure and better heart structure. |
Aug31 |
Fimrenone, a selective MRA antagonist from Bayer shows promising heart failure effects. |
Aug27 |
FDA approves 2nd PCSK9 inhibitor, Repatha, to lower LDL cholesterol |
Aug22 |
Packaging medications together by date to be taken and time of day. |
Aug03 |
New artificial blood vessel coating makes them resistant to thrombosis. |
Jul08 |
Valsartan combined with sacubitril (neprilysin inhibitor) improves heart failure patient survival. |
Jul08 |
153 lab tests for under $10 from a finger prick test done at a local drugstore. |
May23 |
Leptin sensitizer extracted from Chinese Thunder God vine effective in obese mice. |
May20 |
Paired bacteriophage therapy holds promise against superbugs |
May08 |
Putting the brakes on bacterial resistance to antibiotics with targeted antibiotic scheduling. |
May07 |
Pioglitazone to massage mitochondria may help delay Alzheimer's disease |
Apr23 |
Long coding RNA found that regulates brown fat production |
Apr23 |
Currently approved antihelminthic drug effective against MRSA |
Apr21 |
Subcutaneous islet cell transplantation holds promise |
Mar31 |
Medieval garlic and bile potion disrupts MRSA biofilms |
Feb26 |
Dabigatran has higher bleeding risk than warfarin in dialysis patients |
Feb25 |
The concept of minimizing regret in poker: an application for medical treatment? |
Feb20 |
Bourbon virus - a previously unknown Thogotovirus, associated with AKI after tick bite. |
Feb12 |
Rapamycin in bloomberg.com as an anti-ageing drug. |
Feb05 |
BMJ study: Intensify BP treament when SBP > 150, but do it promptly. |
Jan24 |
FDA committee recommends approval of drug to treat invasive aspergillosis. |
Jan09 |
New variant of aminoglycosides does not impair hearing. |
Jan09 |
Monthly dose of PCSK9 inhibitor lowers serum cholesterol |
Dec19 |
Ibuprofen extends lifespan in yeast., worms, and fruit flies. |
Nov17 |
JAMA: New hyperkalemia sorbent effective in reducing hyperkalemia |
Oct12 |
Harvard scientists produce insulin-producing pancreatic beta cells on a large scale. |
Sep01 |
PCSK9 inhibitor arilocumab lowers cholesterol and cardiovascular events |
Aug30 |
Novel heart failure drug shows great promise. |
Aug01 |
Carbapenem-resistant enterobacter becoming more prevalent. |
Jul16 |
New concerns about the safety of niacin. |
Jul14 |
Bacteria found in healthy bladders differ from those in women with incontinence. |
Jul14 |
Hydrogen sulfide generating compound protects stressed mitochondria. |
Jul14 |
Phase 1 trial launched of antibiotic that targets C. difficile. |
May21 |
ZS Pharma presenting data on it's GI potassium sorbent in patients taking RAAS inhibitors at ASH |
May18 |
Urine fibrinopeptide B can be used to detect venous thromboembolism. |
May18 |
Difficult-to-detect bacteria in urine associated with overactive bladder symptoms. |
May18 |
Kallikrein inhibitor ecallantide shows some benefit in ACEI-associated angioedema. |
May18 |
T cells targeting CS1 kill myeloma cells in animals. |
May18 |
Aspirin retards wound healing |
May13 |
Health benefits of resveratrol via red wine called into question by study from Italy |
May07 |
FDA and the Heart Association and other agencies fight over aspirin |
Apr22 |
Have we found the cure for atherosclerosis? D-PDMP a potential candidate. |
Apr22 |
Vancomycin-resistant MRSA identified in a patient in Brazil. |
Apr15 |
NEJM - New drug regimen cures 90% of patients with hepatitis C and cirrhosis. |
Mar29 |
Negative SYMPLICITY HTN-3 trial results published in NEJM |
Mar29 |
SYMPLICITY HTN - 3: Renal artery fails for resistant hypertension |
Mar29 |
Prophylactic rosuvastatin lowers risk of contrast kidney injury. |
Mar29 |
New class of anticholesterol drugs lowers LDL by 50% |
Mar17 |
Large meta-analysis exonerates saturated fat in terms of elevated CV risk. |
Mar13 |
Oxadiazoles make up a new class of antibiotics effective against MRSA. |
Mar13 |
ITPA gene variants markedly affect risk of recurrence of hepatitis C after treatment. |
Mar13 |
Some NSAIDs found to have weak antibacterial activity. |
Mar02 |
Rare gene deletion that protects the obses against type 2 diabetes identified. |
Feb28 |
Beta-blockade found to benefit ESRD patient survival and CV risk |
Feb24 |
New form of pneumococcal vaccine (Prevnar 13) protects elderly adults. |
Jan17 |
Google's smart contact lens project to be piloted to monitor blood sugar levels. |
Jan14 |
New device informs treatment of sleep apnea. |
Jan14 |
Potential rewrite of human research guidelines will facilitate database studies. |
Jan14 |
ZS Pharma announces positive results from extended treatment results of hyperkalemia drug. |
Dec23 |
Staph stopper vaccine developed at U. Iowa |
Dec14 |
Long-term use of proton-pump inhibitors linked to vitamin B12 deficiency. |
Nov25 |
FDA removes certain restrictions from Avandia. |
Nov19 |
Gene therapy shows long-lasting benefits in patients with heart failure. |
Nov19 |
Aldehyde compound stimulates UC-1 to burn body fat. |
Nov19 |
Low-dose dopamine or nesiritide of no help in acute heart failure. |
Nov19 |
Eveolocumab lowers LDL cholesterol in patients with marked hypercholesterolemia. |
Nov18 |
Abatacept slows or halts proteinuria in FSGS. |
Nov18 |
VA NEPHRON D Sttudy in NEJM: Combination ACE-I and ARB treatment for diabetic nephropathy with proteinuria found to be harmful. |
Nov05 |
Sofosbuvir, simeprevir, and ledipasvir combos may cure hepatitis C infection. |
Nov04 |
Many herbal supplements do not contain what's on the label. |
Nov01 |
New oral sorbent targeting hyperkalemia; trial results to be presented at ASN. |
Oct27 |
New K-absorbing compound prevents hyperkalemia with spironolactone. |
Oct20 |
207 nm UV light may be useful to prevent surgical wound infections. |
Oct20 |
Bacteriophages targeting C. difficile: magic bullets against superbugs? |
Oct13 |
Master regulators control gene expression and may affect disease susceptibility. |
Oct13 |
Body uses RNA interference to combat viral infections. |
Oct13 |
Recombinant Human Prion Protein Inhibits Prion Propagation |
Sep25 |
Melatonin stimulates brown fat formation. |
Sep18 |
A mechanism to kill tuberculosis bacteria has been discovered. |
Sep18 |
Arginine therapy may be useful to treat sickle cell disease related pain. |
Sep02 |
Study of saxagliptin for diabetes shows no increase in heart attack risk. |
Aug07 |
Long-term use of calcium channel blockers linked to increased breast cancer risk. |
Aug07 |
New approach to treat diseases with inherited mutations of mitochondrial DNA. |
Aug07 |
Are we smarter than a 10-year old? Quantitative biology yields new insights into bacterial metabolism. |
Jul13 |
Modified HIV vector used to cure 2 genetic disease in children. |
Jul11 |
Rare mutation triggers race to develop new cholesterol drugs. |
Jul05 |
Salsalate lowers blood glucose in type 2 diabetes. |
Jul05 |
Brown fat activation may be responsible for accelerated atherosclerosis in winter. |
Jul05 |
DHA (in fish oil) reduces inflammation via maresin in macrophages. |
Jul05 |
Blocking CD36 might affect inflammation-induced atherosclerosis |
Jun21 |
Silver found to have marked antibacterial properties when added in small amounts to antibiotics. |
Apr07 |
Vitamin D deficiency impedes mitochondrial energy metabolism in muscle. |
Apr05 |
Hepatitis A virus has a cloaking device made from the infected host cell membrane. |
Apr05 |
Malic acid mouth spay for xerostomia. |
Mar20 |
High potency statins increase risk of acute kidney injury (slightly). |
Mar17 |
Macrophages found to play key role in regulating red blood cell levels. |
Mar17 |
Cholecalciferol treatmen of African Americans with hypertension good. |
Mar17 |
Hospital epidemiology study suggests that 1/3 of antimicrobial drug prescriptions in dialysis patients are inappropriate. |
Mar17 |
Fluoroquinolone-resistant E. Coli strains becoming more common in elderly adults. |
Mar17 |
Darbepoietin treatment does not improve survival in anemic heart failure patients. |
Mar09 |
Niacin drug plus antiflushing compound had substantial side effects. |
Mar08 |
New study validates anti-aging effects of resveratrol. |
Mar07 |
High salt diet linked to activation of Th-17 helper cells and multiple sclerosis in mice. |
Feb16 |
Synthetic marijuana linked to acute interstitial nephritis. |
Feb16 |
Dogs cured of type 1 diabetes by gene therapy. |
Feb16 |
Cure for Chagas disease found? |
Feb16 |
Are mycotoxin progenitor molecules found in grains responsible for kidney toxicity? |
Feb16 |
Another study shows increased cardiovascular risk in women with high calcium intake. |
Feb16 |
ADAMTS7, thrombospondin, genetics, and arterial plaque. |
Feb16 |
Off-patent generic drug amlexanox may beneficially affect diabetes. |
Feb16 |
New metabolic pathway identified in Staph bacteria as a target for novel antibiotics. |
Feb16 |
Vitamin D potency varies widely in nonprescription supplements. |
Jan21 |
Regular aspirin use associated with risk of age-related neovascular macular degeneration. |
Jan10 |
DaVita announces drug supply agreement with Fresenius Medical Care. |
Jan10 |
Gene therapy reprograms scar tissue in damaged hearts. |
Dec16 |
Anti-HIV drug protects leukoctyes against Staph. aureus infection. |
Dec13 |
Endothelin antagonist sitaxentan good for CKD with heart disease. |
Dec07 |
FDA issues new labeling requirements for heparin vials. |
Dec06 |
Microbial stowaways in antiseptic products |
Dec06 |
Beta-hydroxybutyrate, histone deacetylase, calorie restriction, and slower aging. |
Dec06 |
Aspirin tablet coatings may give rise to aspirin pseudoresistance. |
Dec01 |
Single-treatment gene therapy targeting telomerase extends lifespan of mouse by 24%. |
Nov26 |
Genes controlling cortisol and aldosterone found to be implicated in human hypertension. |
Nov19 |
Nanotechnology cures multiple sclerosis in mice; are other autoimmune diseases next? |
Nov10 |
Loss of essential blood gene (Atpif1) leads to anemia. |
Nov10 |
Trio of new drugs from Abbott shows high cure rate for hepatitis C. |
Nov05 |
Cinacalcet for hyperparathyroidism trial results published in NEJM. |
Nov05 |
Nabilone shows benefits in managing pain of diabetic neuropathy. |
Nov05 |
Eculizumab for atypical HUS shows promise on longer term treatment. |
Nov05 |
Tolvaptan study shows promising results in polycystic kidney disease. |
Oct25 |
Using human stool to treat C. difficile colon infestations is safe and effective. |
Oct19 |
Bardoxolone study terminated by safety monitoring committee. |
Oct17 |
Cranberry juice unlikely to help in cystitis. |
Oct10 |
Drs. Lefkowitz and Kobilka share chemistry Nobel prize for discovery of G-protein coupled receptors. |
Oct09 |
Neuroprotectant drug effective in maintaining brain function after aneurysm surgery. |
Oct09 |
New class of antimicrobial drugs active against Staph aureus discovered. |
Oct02 |
Increasing levels of FGF2 tied to age-related muscle wasting; reversed with an inhibitory drug. |
Oct02 |
100K units of vitamin D per month does not reduce incidence of colds. |
Sep25 |
Lithium may not work in some patients; and these failures can be detect by lack of gene induction. |
Sep25 |
Bacteriophages targeting Pseudomonas may be used to destroy biofilm. |
Sep19 |
Cost-effectivenes study of renal sympathetic denervation published. |
Sep19 |
Compound found in purple corn reduces macrophage activation in diabetic nephropathy in mice. |
Sep12 |
Fish oil supplement meta-analysis in the news (found no benefit) |
Sep12 |
Serious adverse effects of fluoroquinolones in the news. |
Sep07 |
Nonalcoholic red wine reduced blood pressure better than regular red wine. |
Sep07 |
CKD patients have reduced ability to prevent vascular calcification. |
Sep07 |
Researchers decipher manic gene. |
Sep05 |
Junk DNA turns out to play a major role in cell regulation. |
Aug27 |
Niacin may help the body fight against Staph. aureus infection. via CEBPE gene. |
Aug16 |
CD4 T cells linked to immunologically-mediated atherosclerosis; vaccine may be possible. |
Aug16 |
(+)-naloxone blocks opioid addiction by an immunologic mechanism. |
Aug16 |
Obatoclax and flavopiridol for multiple myeloma. |
Aug09 |
CDC online course in infection prevention in dialysis units. |
Aug09 |
Do neutrophils mediate insulin resistance in obesity? |
Aug03 |
Diacetyl, an artificial butter flavor used in popcorn, linked to Alzheimer's disease worsening. |
Aug02 |
KDIGO releases new, 2012 version of anemia guidelines; 9.0 g/dL Hb is the new lower bound. |
Jul21 |
FDA: Seizure risk from cefepime in patients with renal impairment. |
Jul18 |
FDA approves second diet drug within a month. |
Jul12 |
Circadian clock cryptochromes tied to development of type 2 diabetes. |
Jul12 |
Cucurmin reduces incidence of type 2 diabetes in randomized control trial. |
Jul10 |
FDA approves viral load test for patients with CMV infection. |
Jul05 |
Metformin may boost brain function via stimulation of new neuron formation. |
Jul05 |
Fracture benefits of vitamin D in the elderly appear only at doses greater than 800 IU / day. |
Jun28 |
Favorable early results after renal denervation in CKD. |
Jun28 |
FDA approves new weight loss drug lorcaserin (Belviq) |
Jun27 |
Considerable variability found between 25-D assays. |
Jun23 |
Olmesartan side effects mimic celiac disease. |
Jun20 |
Anti-adhesion molecule therapy for urinary tract infection. |
Jun20 |
Higher urinary sodium output in the PREVEND trial linked to higher BP, uric acid, and albuminuria. |
Jun20 |
Intestinal bacteria secrete neurotransmitters (GABA) that may play a role in inflammation. |
Jun13 |
Healthy human microbiome characterized. |
Jun13 |
Thiazolidinedione use may increase risk of macular edema. |
Jun13 |
Apramycin may be a useful antibiotic that causes little damage to hearing. |
Jun07 |
Abiraterone shows good results in advanced prostate cancer. |
Jun07 |
High caffeine levels protective against Alzheimer disease. |
May29 |
FDA issues warning about use of high total base content hemodialysis solutions. |
May29 |
AUF1 gene plays central role in aging, inflammation, and cancer. |
May19 |
Short-term azithromycin treatment associated with increased cardiovascular death risk. |
May19 |
Study of HDL genetic variants casts doubt on the beneficial impact of higher HDL levels. |
May19 |
New MRI technique can follow changes in brain pH. |
May19 |
Renal denervation shows encouraging results for resistant hypertension. |
May04 |
Mechanism of increased CV risk with NSAIDs explained. |
May04 |
Cardiovascular risks of varenicline not confirmed. |
May01 |
FDA approves everolimus for treatment of kidney angiomyolipomas associated with tuberous sclerosis. |
May01 |
Avastin and Lucentis similarly effective in treating wet age-related macular degeneration. |
May01 |
Interferon treatment can cause depression. |
Apr26 |
FDA issues safety warning about using aliskiren plus an ACEI or ARB in diabetes or CKD. |
Apr26 |
Want more bone cells and less fat cells? Endoglin may be the answer. |
Apr17 |
Proteins can fold in a water-free environment and develop thermal resistance |
Apr05 |
As yet unidentified factor from fat stem cells can markedly increase glucose uptake in muscle. |
Mar27 |
FDA approves peginesatide to treat anemia in adult dialysis patients. |
Mar27 |
LDL antibodies reduce LDL cholesterol by 70% in patients already taking statins. |
Mar20 |
Antiplatelet therapy in CKD patients with heart disease called into question. |
Mar13 |
FDA nd Congress launches initiatives to deal with drug shortages. |
Mar08 |
FDA considering making many drugs over the counter. |
Mar08 |
Silver mouthwash to treat oral Candidiasis. |
Mar08 |
Animal studies suggest that nitric oxide gas inhalation after stroke improves brain perfusion. |
Mar08 |
New class of drugs can reverse fibrosis in injured and diabetes-afflicted kidneys. |
Mar02 |
FDA: Statins and protease inhibitors taken together can increase risk of muscle injury. |
Feb28 |
FDA adds diabetes, memory loss warning to statins. |
Feb26 |
Takeda's GP40 agonist drug lowers blood sugar in type 2 diabetes without hypoglycemia risk. |
Feb22 |
FDA advisory panel votes to approve weight loss drug Qnexa (phentermine/topiramate) |
Feb18 |
Four new drugs will change prostate cancer care. |
Feb18 |
Hypervirulent resistant Klebsiella bacterium is next superbug in waiting. |
Feb18 |
New link identified between insulin resistance ant gut inflammation via fatty acid synthase. |
Feb18 |
Polystyrene nanoparticle block gut iron absorption. |
Feb14 |
Amino acid response pathway, autoimmune disease, tolerance, and a Chinese herb. |
Feb14 |
Paricalcitol fails to improve LVH in CKD patients in randomized PRIMO trial. |
Feb09 |
CDC issues safety alert regarding proton pump inhibitors and risk fo C difficile diarrhea. |
Feb09 |
Bexarotene rapidly clears Alzheimer type plaque from brains of mice. |
Feb09 |
FGF21 (this is NOT FGF23) good for reducing fat mass, but bad for bone density. |
Feb09 |
Coronary artery disease in British males linked to common Y-chromosome haplogroup. |
Jan26 |
Chemists synthesize artificial cell membrane. |
Jan12 |
Routine aspirin may cause harm |
Jan10 |
Dabigatran linked to risk of acute coronary events. |
Dec13 |
CKD may cause breakdown of tight junctions between intestinal epithelial cells. |
Dec13 |
Statins reduce plaque by affecting the CCR7 chemokine receptor on macrophages. |
Dec11 |
One session of gene therapy for hemophilia B leads to prolonged increase in clotting factor. |
Dec08 |
New purine synthesis blocking drug kills malaria parasites. |
Dec06 |
U.S. FDA considering the relative efficacy and safety of Affymax to treat CKD anemia. |
Dec06 |
EPO involved in the spread of cancer. |
Nov28 |
Amgen negotiates 2 large anemia drug contracts with DaVita and Fresenius. |
Nov16 |
ASN; PRIMO study shows no benefits of paricalcitol on LVH in patients. |
Nov16 |
Higher dose statins reduce coronary artery plaque. |
Nov16 |
Niacin may not improve hard outcomes. |
Nov09 |
Potassium channels in the hypothalamus linked to blood glucose control. |
Nov01 |
Am Heart Assoc High BP Research Council Fall 2011 Meeting abstracts |
Oct28 |
Sulodexide fails to show benefit in diabetic kidney disease in large trial. |
Oct26 |
Furanocoumarin-free grapefruit may have less interference with prescription drugs. |
Oct26 |
FDA panel to review anemia drug peginesatide (from Affymax) on Dec. 7, 2011. |
Oct26 |
Apixaban better than warfarin for atrial fibritllation. |
Oct26 |
Taking at least one BP med at bedtime lowers cardiovascular risk. |
Oct20 |
Elderly (over 75 years) die not infrequently due to aggressive prostate cancer spread. |
Oct20 |
Abbott labs to spin off drug division as a separate company. |
Oct14 |
Higher serum 25-D levels of great importance in fighting off tuberculosis infection. |
Oct14 |
Do variants of macrophage inhibitory factor gene account for access infections? |
Oct14 |
Activating fetal hemoglobin production in mice reverses sickle cell disease. |
Oct14 |
Bacteria-derived bile acids linked to efficacy of statins. |
Oct14 |
JASN publishes a series of papers regarding genetic basis of kidney disease risk in Blacks. |
Oct14 |
mRNA-mediated gene regulation shown to be of increasing importance. |
Oct11 |
Thiazides may be especially useful to treat hypertension from calcineurin-inhibitor drugs. |
Oct11 |
Link between FGF23 and LVH strengthened by studies in mice, rats, and patients. |
Sep28 |
Hb target of 11-13 better than 9-11 in predialysis CKD patients accoding to a Japanese randomized trial |
Sep27 |
Eculizumab approved by FDA to treat atypical hemolytic uremic syndrome. |
Sep18 |
Risk of pancreatitis and pancreatic cancer with sitagliptin and exenatide highlighted. |
Sep15 |
Like yourself and other people? It could be due to your oxytocin receptor genotype. |
Sep15 |
DaVita Clinical Research announces biorepository services to facilitate research. |
Sep15 |
MRSA in the United States becoming resistant to combination antibacterial ointments. |
Sep15 |
NEJM: Apixaban better than warfarin to treat atrial fibrillation. |
Sep13 |
Sensipar gets FDA label change focusing on hypocalcemia monitoring and seizure risk. |
Sep03 |
FDA updates kidney failure warning for zoledronic acid (Reclast) osteoporosis drug. |
Aug10 |
Soy tablets of no benefit in preventing bone loss in postmenopausal women. |
Aug10 |
Panfungal vaccine based on injection of killed Baker's yeast? |
Aug03 |
4-D Substudy suggests that low homoarginine levels associate with sudden death. |
Jul21 |
FDA approves ticagrelor (Brilinta) to treat acute coronary syndrome. |
Jul21 |
FDA panel votes against dapagliflozin, casting doubt over the drug class of SGLT2 inhibitors. |
Jul21 |
Knockout model shows that kidney dopamine is an important modulator of blood pressure. |
Jul12 |
Kv7.4 potassium channel in blood vessels linked to control of blood pressure. |
Jul05 |
NSAIDs associated with increased risk of atrial fibrillation. |
Jul01 |
E. coli can survive in streambeds for months. |
Jul01 |
New class of antiangiogenesis drugs discovered from South American tree. |
Jun28 |
Collagen-binding protein allows dental S. mutans bacteria to attach to heart valves. |
Jun28 |
Anticholinergic dugs, including diphenhydramine linked to cognitive impairment and mortality risk in the elderly. |
Jun28 |
NEJM: Bardoxolone methyl improves kidney function in type 2 diabetic patients. |
Jun23 |
NEJM: Telaprevir provides dramatic improvement in hepatitis C patients. |
Jun19 |
E.Coli O104 that causes HUS sequenced and complete genome released. |
Jun16 |
FDA Medwatch: Ongoing safety review in progress re pioglitazone and possible bladder cancer risk. |
Jun16 |
FDA approves Nujolix (belatacept) for organ transplantation. |
Jun13 |
FDA Medwatch: Risk of thyroid calcitonin tumors (in rodents) and pancreatitis with liraglutide. |
Jun10 |
France and Germany suspend approval for pioglitazone due to bladder cancer risk question; other countries not yet. |
Jun10 |
FDA: Finasteride or dutasteride may increase risk of high-grade prostate cancer. |
Jun10 |
Inhibition of insulin degrading enzyme may help control type 2 diabetes. |
Jun09 |
FDA-mandated labeling change for simvastatin regarding risk of higher dosages. |
Jun09 |
SHARP trial (simvastatin plus ezetimibe in CKD) results published in the Lancet. |
Jun09 |
FDA: Myopathy risk of high-dose (80 mg) simvastatin close to 50%; limitations to use recommended. |
Jun09 |
Growing role of antibiotic peptides. |
Jun07 |
Medicare to offer more waivers pertaining to e-prescribing noncompliance penalty. |
Jun07 |
Gene therapy reverses type 1 diabetes in mice. |
Jun02 |
New variety of MRSA originating in animals identified in Europe. |
May31 |
Affymax/Takeda files new drug application (NDA) for peginesatide to treat anemia. |
May28 |
Lactate shuttle in human tumors. Is chronic use of lactate-based PD fluid a risk? |
May28 |
Chronic estrogen exposure may increase blood pressure via superoxide; reversed by resveratrol. |
May26 |
Addition of niacin to simvastatin fails to protect the heart and may increase stroke risk |
May24 |
Turkey tail mushroom found to be very effective in suppressing prostate tumors in mice. |
May19 |
Avandia (rosiglitazone) REMS (Risk Evaluation and Mitigation Strategy) document. |
May19 |
Modifying Treg cells allows transplantation of human skin onto mice. |
May19 |
Deuterium-enriched vitamin A slows rate of age-related macular degeneration in a mouse model. |
May19 |
Study compares three induction immunosuppressants, finds the cheapest one, alemtuzumab, to be noninferior. |
May17 |
FDA advisory panel will convene to reconsider approval of fenofibrate |
May16 |
IDOL, inducible LKL receptor degrading molecule, may be target for cholesterol lowering. |
May13 |
FDA approves boceprevir to treat hepatitis C. |
May12 |
Losartan might protect against disuse muscle atrophy (in mice). |
May03 |
Sodium retention action of thiazolidinediones linked to increased proximal tubular absorption. |
May03 |
Link to EPOGH study in JAMA on urinary sodium and CV death risk. |
Apr29 |
Avastatin equivalent to Lucentis for treating wet macular degeneration, but much cheaper. |
Apr29 |
FDA panel recommends approval of telaprevir for hepatitis C. |
Apr28 |
Viral breakthrough in HBV treatment with nucleoside analogs may be due to noncompliance. |
Apr28 |
Case report of a possible link between kava tea ingestion and rhabdomyolysis in a bicyclist. |
Apr28 |
Vitamin E helps reduce nonalcoholic fatty liver more than metformin in diabetic kids. |
Apr26 |
Boceprevir and telaprevir each show promising results in patients with hepatitis C. |
Apr26 |
25D blood level differences explain 40% of difference in blood pressure between blacks and whites. |
Apr22 |
Pirfenidone gives promising results in treating diabetic nephropathy. |
Apr12 |
Am Acad Neurol issues guidelines regarding treatment of diabetic nerve pain. |
Mar30 |
Antibiotics wrapped in nanofibers show dramatically increased efficacy. |
Mar29 |
Phase 1 safety trials for begin for deuterium-based drug targeting diabetic kidney disease. |
Mar29 |
Nicotine found to increase blood levels of HbA1c in diabetic patients. |
Mar25 |
GAO issues reports on monitoring of oral drugs for ESRD patients |
Mar24 |
Rockwell proceeding with Phase III trial of dialysate-added iron. |
Mar24 |
Ok, you know about FGF23. But FGF19 may be even more important in glucose metabolism. |
Mar24 |
Do you still ask about green or yellow phlegm in your patients who are coughing? |
Mar24 |
Multidrug-resistant Klebsiella pneumonia found in Los Angeles County area acute care hospitals. |
Mar21 |
Canadian observational data suggests that dual ACEI/ARB treatment is risky in the elderly. |
Mar17 |
Cardiac injection of autologous stem cells markedly improves heart failure. |
Mar15 |
11beta-hydroxysteroid dehydrogenase type 1 linked to apple vs. pear-shaped phenotype. |
Mar15 |
Wnt receptor Frizzled-9 involved in bone mineralization. |
Mar15 |
Snapin protein found to control insulin release from pancreatic beta cells. |
Mar12 |
Endothelin-A antagonist atrasentan reduces UACR in diabetics in small phase 2 study. |
Mar12 |
Wnt1 can stimulate new blood vessel formation and also improve blood flow. |
Mar05 |
NEJM paper compares loop diuretic strategies for acute heart failure. |
Mar02 |
Glycogen synthase kinase 3 beta (GSK3B) antibody lowers blood pressure in animals. |
Mar02 |
Self-treatment of drug allergy rash with a tanning be can lead to toxic epidermal necrolysis. |
Feb28 |
Older patients confused about how to time taking of multiple drugs. |
Feb28 |
Gut bacteria can affect hepatic lipid metabolism |
Feb24 |
FDA approves saxagliptin (Onglyza) labeling to include patients with CKD |
Feb24 |
Missing sugar molecule raises diabetes risk in humans |
Feb16 |
Sanofi finally seals the deal to buy Genzyme. |
Feb16 |
Rockwell commences PRIME study of dialysate-added iron. |
Feb11 |
New genetic cause of primary hyperaldosteronism identified, and it's not rare. |
Feb07 |
Pivotal discoveries in age-related macular degeneration. |
Feb04 |
Mutation points to adenosine as playig a role in arterial calcification. |
Feb02 |
NEJM: Fidaxomicin a new, more effective treatment for Clostridium difficile. |
Feb01 |
Sanofi still pursuing offer to acquire Genzyme. |
Feb01 |
FDA adverse event drug reporting system flags several drugs used in CKD. |
Feb01 |
FDA decides to not approve diet drug Orexigen's Contrave at the present time. |
Jan27 |
Who needs insulin? UT Southwestern study shows that without glucagon, insulin may not be that important. |
Jan27 |
Rockwell to launch phase 3 studies of iron-fortified dialysate. |
Jan27 |
Circadian rhythms demonstrable even in red blood cells. |
Jan21 |
Inhaled insulin fails to get FDA approval; 2 additional studies were requested. |
Jan15 |
National Library of Medicine's Daily Med website for quick access to drug package inserts. |
Jan14 |
Coffee, sex (hormones), and diabetes... |
Jan12 |
JAMA: Candesartan linked to better survival in heart failure than losartan. |
Jan12 |
Common painkillers linked to increased risk of vascular complications. |
Jan10 |
Statins may be harmful after hemorrhagic stroke. |
Dec28 |
FDA clears Novartis' triple antihypertensive drug for marketing. |
Dec22 |
Metreleptin a promising new treatment for type 1 diabetes. |
Dec03 |
Fresenius enters into agreement with Galenica pharma to develop new IV iron products. |
Nov30 |
AMAG's Feraheme modifies its labeling, but FDA does not require a black box warning. |
Nov30 |
Prolyl hydroxylase inhibitor FG-2216 results in increased EPO production by ESRD kidneys and liver. |
Nov30 |
Keryx announces positive results for Zernez, an iron-based phosphate binder |
Nov30 |
M3 muscarinic receptor on pancreatic beta cells key to insulin release. |
Nov30 |
Institute of Medicine releases new guidelines for vitamin D intake (600-800 IU) |
Nov30 |
Source of protection against saturated fat (Angptl4) found, and 3% of people don't have it. |
Nov23 |
Propoxyphene withdrawn from the U.S. market due to risk of cardiotoxicity. |
Nov21 |
Bardoxolone INCREASES GFR by a substantial amount in type 2 diabetic CKD patients |
Nov18 |
Statins boost bacterial killing by phagocytes. |
Nov17 |
Radiofrequency zapping of renal nerves in CKD lowers blood pressure substantially. |
Nov17 |
NEJM: New CETP inhibitor anacetrapib shows promise in affecting LDL and HDL levels |
Nov16 |
FDA panel recommends approval of Benlysta to treat lupus flares. |
Nov16 |
Xarelto and other warfarin alternatives about to hit the U.S. market. |
Nov14 |
Large RCT has good news and bad news for nesiritide (Natrecor). |
Nov11 |
Pioglitazone slows down cyst growth in a rat model of PKD. |
Nov08 |
Rush to judgement? Rosiglitazone not linked to heart events in BARI 2D |
Nov08 |
Genistein (from soy) may help prevent spread of prostate cancer cells. |
Nov08 |
Pentazocine stabilizes retina in a mouse model of diabetes. |
Nov04 |
Addition of telaprevir increases hepatitis C cure rates. |
Nov02 |
New liver hormone linked to selenoprotein P associated with insulin resistance. |
Oct29 |
Deuterated fatty acids resistant to oxidative damage. |
Oct29 |
AMAG Q3 report discusses potential black box warning |
Oct22 |
Salt sensitivity linked to vasopressin via induction of brain protein synthesis. |
Oct15 |
NEJM: Regulatory action on rosiglitazone by the FDA. |
Oct14 |
FDA CV and Renal Drugs Advisory Committee meets Oct 18th to consider TREAT study results. |
Oct12 |
Pharmacy benefits group attempts to predict drug non-compliance at an early stage. |
Oct09 |
More on FDA-mandated withdrawal of Meridia (sibutramine) from the U.S. market. |
Oct09 |
Androgen deprivation therapy causes structural bone decay. |
Oct09 |
Abbott removes weight loss drug Meridia (sibutramine) due to stroke and heart disease risk. |
Sep25 |
Octagam IVIG withdrawn from sale due to thromboembolic event risk. |
Sep23 |
FDA to limit patient access to rosiglitazone (Avandia) |
Sep23 |
Abbott Labs buys international rights to CKD prevention drug bardoxolone |
Sep23 |
Three proteins reliably increase in the blood during transplant rejection. |
Sep23 |
European Medicines Agency recommends that Avandia (rosiglitazone) be banned from the European market. |
Sep22 |
Weight-based dosing of taribavirin causes less anemia than ribavirin in hepatitis C treatment. |
Sep15 |
Defective ABCB4 gene impedes cholesterol excretion into the bile. |
Sep10 |
NIH launches beta version of new tool to identify unknown pills. |
Sep10 |
University of Kansas researchers develop compound that reverses diabetic neuropathy in mice. |
Sep10 |
Alzheimer amyloid precursor protein function discovered to be involved with iron storage |
Sep09 |
FDA issues new safety alert re gadolinium-containing contrast agents and NSF. |
Sep08 |
Quercetin (found in onions and black tea) aggravates kidney cancer in rats |
Sep03 |
Cranberry juics blocks ability of Staph aureus bacteria to form biofilm in the urinary bladder. |
Sep03 |
Fish oils inactivate inflammatory effects of macrophages present around fat cells |
Sep03 |
Novel antimalarial drug candidate shows promise. |
Sep03 |
First clinical trials completed on potent new drug against hepatitis C. |
Aug31 |
Could a vaccine against Staph aureus toxin alpha hemolysin (Hla) help in exit-site infection? |
Aug31 |
Large study debunks notion that statins may be associated with cancer. |
Aug29 |
Molecule found that deactivates selective components of the complement system. |
Aug26 |
Genetic variants in protein kinase C affect CKD progression in type 2 diabetics of Chinese descent. |
Aug26 |
Novartis options siRNA drug from Quark Pharma to reduce AKI and delayed allograft function. |
Aug26 |
Back to the future: Renin profiling claimed to be useful in predicting response to RAAS inhibitors or beta-blockers. |
Aug26 |
Naringenin from grapefruits shows promise as a treament for type 2 diabetes |
Aug21 |
KDIGO initiative for improved drug dosing in patients with kidney disease |
Aug20 |
Two FDA approved drugs cause HIV to mutate itself to death in mice. |
Aug19 |
Vitamin D may improve allergic aspergillosis related diseases. |
Aug17 |
FDA approves longer use of (200 days) of valganciclovir for CMV prophylaxis post transplant. |
Aug04 |
CMS implements steps to close donut hole for pharmaceutical funding |
Aug02 |
New drug resistant strain of E. Coli spreading in the U.S. as well as abroad. |
Jul30 |
Calcium supplements increase the risk of heart attack in postmenopausal women. |
Jul28 |
Biotrends data suggests that use of ESAs for stage 4 CKD is falling. |
Jul28 |
Presence of nonhuman sialic acid in biotech drugs can provoke an immune response. |
Jul24 |
Marcrophage fatty acid synthase a new target to prevent atherosclerosis. |
Jul21 |
Glitazones act NOT as PPAR-gamma agonists, but by blocking PPAR phosphorylation by ckd5. |
Jul20 |
Inhaled insulin comes one step closer to FDA approval. |
Jul20 |
FDA approves generic version of transdermal clonidine. |
Jul15 |
FDA review panel shows mixed opinions about whether Avandia should be withdrawn from sale. |
Jul09 |
More on the FDA and Avandia (rosiglitazone) safety issues. |
Jul08 |
Getting forgetful? P7C3 seems to help aging rats. |
Jul08 |
Rosiglitazone safety issues continue to be unresolved. FDA to reveal new data tomorrow. |
Jul06 |
Robert Brenner named CEO of start-up company focusing on use of stem cells to treat kidney disease. |
Jul02 |
Why 25 vitamin D levels may be low in uremia. |
Jul02 |
Honey as a topical antibiotic explained. |
Jun24 |
Selective estrogen compound activates cell-surface receptors only, may confer vascular protection. |
Jun22 |
Wall Street Journal article highlights food - drug interactions. |
Jun22 |
Affymax shares fall after cardiovascular risk concerns raised about hematide. |
Jun17 |
Once-weekly exenatide controls weight and HbA1c in DURATION-4 study. |
Jun10 |
Allopurinol markedly slows progression of CKD in small randomized trial. |
Jun10 |
The secret of why red wine and green tea block some cancers may be revealed. |
Jun02 |
Amgen drug denosumab (Prolia) approved by the FDA to fight osteoporosis. |
May26 |
FDA mandates labels change for proton pump inhibitors warning of fracture risk. |
May26 |
Watson files abbreviated new drug application for sevelamer carbonate. |
May18 |
Teva Pharmaceutical announces tentative FDA approval of generic cinacalcet (Sensipar) |
May18 |
Pregnenolone sulfate may reduce inflammatatory mediator production by blood vessels. |
May12 |
Why multiple drug treatment may be required to treat hepatitis C virus infection. |
May11 |
Proton pump inhibitors increase risk of fractures and of nosocomial C. difficile |
Apr28 |
Eating hot peppers significantly increases (doubles) post-prandial energy expenditure as well as fat oxidation. |
Apr28 |
Anabolic steroid use in healthies impairs left ventricular relaxation by 50% and also ejection fraction. |
Apr28 |
RCT shows that high-dose B vitamins associated with increased risk of progression and CV events in diabetics. |
Apr28 |
Depomedrol and ACTH have different effects on osteonecrosis of the hip, VEGF. |
Apr24 |
FDA approves Zortress(R) - everolimus - for organ transplant use. |
Apr11 |
Nanovaccine stops type 1 diabetes from developing in mice. |
Apr07 |
Heparin tested under the new standard may be 10% less potent than previously. |
Mar29 |
U.S. judge invalidates gene patent |
Mar29 |
Novel antivirus compounds target the viral envelope, and are broadly effective. |
Mar28 |
Toronto conference on Nephroprevention to be held October 1-2, 2010. |
Mar23 |
Novel compound targetting DC-SIGN receptor developed against HIV |
Mar22 |
Effect of UV sunlight rays on multiple sclerosis -- something other than vitamin D at work? |
Mar08 |
Good Vitamin D levels needed for adequate killer T cell function. |
Mar04 |
Pycnogenol (pine bark extract) reduces kidney damage in hypertension. |
Mar04 |
Prostate cancer vaccine (Dendreon) improves survival by 40% in patients with advanced disease. |
Mar02 |
FDA advisory panel recommends approval of belatacept for kidney transplants. |
Feb28 |
Rising threat of infections due to drug-resistant Gram-negative infections |
Feb23 |
AHA/ACC issue Science Advisory re heart risk and thiazolidinedione drugs. |
Feb22 |
Mutations in gene encoding K channel KCNN3 associated with atrial fibrillation. |
Feb16 |
Affymax readies blockbuster alternative to Epogen. |
Feb12 |
NKDEP offers a suggested approach to drug dosing in CKD |
Feb12 |
Tetrahydrobiopterin (BH4) a drug already used in humans, prevents diastolic heart failure in mice. |
Feb11 |
GLP-1 analogue designed to be taken weekly shows promising results in diabetics. |
Feb10 |
3SBio licenses China rights to ferric citrate as a phosphate binder. |
Feb01 |
Serious liver disorder associated with didanosine (drug used to treat HIV) use |
Jan27 |
Think you know how platelets are made? Guess again. |
Jan27 |
Longevity effects of human growth hormone debunked by long-lived deficients. |
Jan12 |
Intranasal and intracranial TGF-alpha restores motor function after stroke in rats. |
Jan06 |
NEJM FDA op ed piece: Time for reevaluation of anemia drugs. |
Jan06 |
FDA plans safety panel on 3 drugs for anemia. |
Jan06 |
Study examines the mathematical benefits of drawing multiple patient lab samples. |
Jan06 |
Genetic survey of clear cell renal cancer samples identifies new gene abnormalities. |
Jan05 |
Vitamin C arrests senescence in mice mutated to mimic Werner syndrome. |
Jan05 |
Glycyrrhizin increases ability of skin to ward off infection. |
Dec29 |
High price of FDA approval - the case of colchicine. |
Dec23 |
Caloric restriction longevity effects linked to telomerase activity. |
Dec22 |
Deoxycytidine kinase enzyme shown to profoundly affect adaptive immune system. |
Dec12 |
Star fruit intoxication in patients with moderate CKD not yet on dialysis |
Dec08 |
FDA panel recommends approval of everolimus for transplant rejection with a risk mitigation plan. |
Dec08 |
Drug reimportation re-emerges in health care debate. |
Dec04 |
Observational study suggests remarkable protection against graft-versus-host disease by statins. |
Dec03 |
Finasteride linked to increase risk of breast cancer in men. |
Dec03 |
What is "pay for delay" and how does it affect availability of generic drugs? |
Dec02 |
Urea concentrations between 10 and 40 mM induce reactive oxygen species in cell culture. |
Dec01 |
TLR2 (toll-like receptors) linked to inflammatory damage in atherosclerotic plaque. |
Dec01 |
Are peptoids that disable autoreactive T cells the next step in treatment of autoimmune disease? |
Dec01 |
Protein Kinase G (PKG) controls brown fat abundance; may be manipulated in treatment of obesity. |
Nov27 |
Stress-related blood pressure linked to phosducin. |
Nov26 |
Rituximab helps preserve beta cell function in patients with early type 1 diabetes. |
Nov19 |
FDA issues warning letters to 22 websites marketing health products with unapproved claims. |
Nov18 |
Niacin plus statin no better than niacin alone in elderly patients with CAD. |
Nov18 |
Genzyme cancels development of Renvela successor. |
Nov17 |
FDA: Omeprazole and clopidogrel drug:drug interaction reducing efficacy of clopidogrel |
Nov15 |
NEJM: Extended-release niacin better than ezetimibe (Vytorin) for atherosclerosis reduction |
Nov14 |
Myostatin inhibitors increase muscle mass and strength in monkeys via gene therapy. |
Nov14 |
Why certain antibiotics like cipro and tetracycline counteract each other |
Nov10 |
Insurers, drugmakers turn to Senate for changes to health care reform bills. |
Nov06 |
1930s gonorrhea drug acriflavine blocks HIF-1 induced new blood vessel proliferation. |
Nov05 |
Benlysta (belimumab) phase III trial for lupus gives positive results. |
Nov05 |
NEJM: Hematide corrects anemia due to ESA-induced pure red cell aplasia. |
Nov04 |
FDA unveils "Safe Use Initiative" to reduce medication-related side-effects. |
Nov04 |
TLR4 on macrophages may mediate the immune system response to excess fat. |
Nov04 |
ROMK downstream pathway clarified; may lead to new drugs to combat hyperkalemia in CKD |
Nov03 |
FDA warns about adverse renal effects of Byetta (exenatide) |
Nov03 |
One particular MRSA strain associated with high mortality rates. |
Nov03 |
Proton-pump inhibitors associated with multiple side effects. |
Oct30 |
TREAT trial of darbepoetin in diabetics with preESRD shows no benefit and increased stroke risk. |
Oct29 |
Rockwell announces completion of Phase IIB study of dialysate-supplemented iron therapy. |
Oct28 |
50K or ergocalciferol every 2 weeks as maintentance treatment for vitamin D deficiency. |
Oct28 |
Shire's Fosrenol approved in Europe for preESRD patients |
Oct28 |
Fish oil (DHA) metabolite resolvin 2 found to have marked anti-inflammatory activity |
Oct28 |
Gut bacteria linked to diet, immune system functioning via short chain fatty acid receptor |
Oct26 |
Histone released from damaged cells during trauma or sepsis damages blood vessels. |
Oct23 |
FDA authorizes use of IV peramivir for hospitalized patients with H1N1 infection. |
Oct23 |
FDA Medwatch reports another case of PML after rituximab in a rheumatoid arthritis patient. |
Oct19 |
Black box warning for Dexferrum (iron dextran) modified after anaphylactic reactions. |
Oct19 |
FDA delays approval of Amgen's denosumab to treat osteoporosis. |
Oct19 |
Uloric shown particularly effective in lowering hyperuricemia in patients with mild-moderate CKD. |
Oct15 |
The gadolinium NSF story from the product liability perspective, focus on G.E. |
Oct01 |
FDA announces new manufacturing standards for heparin that may change its potency. |
Sep25 |
Januvia (sitagliptin) linked to increased pancreatitis risk |
Sep24 |
200g/day fructose supplement increases systolic BP by 6 mm Hg, prevented by allopurinol. |
Sep24 |
AJKD issues containing KDOQI guidelines now freely available as .pdf files |
Sep18 |
Metformin or insulin do not lower levels of inflammatory markers in diabetics. |
Sep13 |
Multidrug resistant Staph aureus recovered from 7 public beaches around Puget Sound. |
Sep11 |
Fresenius launches telemonitoring system for dialysis patients. |
Aug30 |
NEJM: Ticagrelor better than clopidogrel as an anti-platelet agent post acute coronary syndrome. |
Aug30 |
NEJM: Free full text paper on dabigatran vs. warfarin for stroke prevention in atrial fib. |
Aug30 |
Pradaxa (dabigatran) outperforms warfarin by a mile for stroke prevention with a. fib. |
Aug28 |
About 1/3 of people don't activate clopidogrel very well due to gene variants. |
Aug28 |
High LDL cholesterol may thin bone by stimulating RANKL. |
Aug28 |
New gene controlling formation of adipocytes identified. |
Aug24 |
Mice eating a low-carb diet show increased atherosclerosis and decreases in vascular progenitor cells. |
Aug24 |
FDA announces ongoing monitoring of liver injury associated with Orlistat. |
Aug21 |
Oxidative stress in CKD patients linked to malfunctioning mitochondria. |
Aug21 |
Excess cholesterol can affect heart rhythm via potassium channels |
Aug21 |
When vitamin D levels low, macrophages get overloaded with cholesterol. |
Aug19 |
Vitamin D regulation of immune function via cathelicidin conserved in all primates. |
Aug19 |
Heart failure risk with rosiglitazone double that with pioglitazone. |
Aug19 |
Pot for prostate cancer. |
Aug19 |
Klotho gene reduces blood pressure and extends lifespan. |
Aug18 |
Pharmacologic development of sirtuin activators - reviewed in NY Times |
Aug13 |
Toray develops insulin nasal spray. |
Aug11 |
GIFT15 treatment modified B lymphocytes and reverses multiple sclerosis in the lab; may have potential in lupus as well. |
Aug11 |
Gene therapy restores alpha-1-antitrypsin activity in lungs of patients with hereditary deficiency. |
Aug11 |
Anti-RAS drug restores insulin production in animal model of diabetes. |
Aug11 |
Release of fat-stored substances during dieting or other weight loss: Example of cannabis. |
Aug06 |
Itch-specific neurons identified in mice. |
Aug06 |
Hypertension associated with VEGF-inhibitors linked to nitric oxide. |
Jul31 |
FDA approves saxagliptin for use in type 2 diabetes. |
Jul31 |
FDA warns of colchicine side effects when co-prescribed with clarithromycin and other drugs. |
Jul31 |
Resveratrol found to have potent anti-infammatory effects. |
Jul31 |
Lecithin found to have beneficial effects on fat metabolism via PPAR-alpha |
Jul31 |
Avasting (bevacizumab) may be potent treatment for diabetic macular edema. |
Jul30 |
Cell biology mechanisms of genistein (present in soybeans) inhibition of prostate cancer clarified. |
Jul28 |
NIH halts trial of sildenafit in patients with sickle-cell disease and pulmonary hypertension. |
Jul28 |
How do drugs like cromolyn that affect mast cells affect adipocytes and metabolic syndrome? |
Jul28 |
Defer0xamine to treat diabetic foot ulcers? In mice, yes. |
Jul23 |
Clinical trial of injecting pig insulin-producing cells into humans begins. |
Jul19 |
HGS/Glaxo drug Benlysta shows some effectiveness against lupus in phase 3 clinical trial. |
Jul14 |
Senate backs 12 year non-compete shelter for biotech drugs |
Jul13 |
DaVita Clinical Research appoints Dr. Mahesh Krishnan as Vice President |
Jul08 |
Costimulation blocker plus alefacept allow monkeys to tolerate transplanted kidneys. |
Jul08 |
Is PEDF "the" link between obesity and type 2 diabetes? |
Jul08 |
Anti-ageing effects of rapamycin in mice in the news. |
Jul05 |
Aldosterone regulates ENac levels via Per1 - a protein mediating circadian rhythms. |
Jul02 |
Fresenius opens specialty pharmacy for renal patients in Nashville. |
Jul02 |
NEJM: Phospholipase A2 receptor is a target antigen in 70% of patients with idiopathic membranous nephropathy. |
Jul02 |
Rebound hyperacidity, reflux symptoms in normals after stopping proton pump inhibitors |
Jul02 |
Enalapril or losartan markedly slow progression of eye damage in type 1 diabetics. |
Jul01 |
FDA advisory panel recommends banning Vicodin and Percocet and limiting maximum acetaminophen doses |
Jun30 |
Common gene polymorphism affecting calcium excretion (claudin 14) linked to both kidney stones and osteoporosis. |
Jun26 |
Mechanism of BPA (bisphenol A) related infertility defined in mice. |
Jun20 |
New prostate cancer drug ipilimumab shows dramatic results in 2 patients. |
Jun13 |
FDA issues alert on increased death risk in liver transplant patients taking Rapamune. |
Jun13 |
Sevelamer carbonate (Renvela) approved for sale in the European Union |
Jun10 |
Ferric citrate found to bind phosphate in phase II study with no marked adverse effects. |
Jun05 |
Aldosterone levels found to be increased in chubby teenage boys. |
Jun05 |
Telaprevir substantially increases hepatitis C cure rates (NEJM) |
Jun04 |
Halofuginone, Th17 cells, and autoimmunity. |
Jun03 |
FDA reports on serious liver failure risk in patients taking propylthiouracil. |
May29 |
FDA: Serious fungal infections associated with TNF-alpha blockers. |
May29 |
Risks of aspirin outweight benefits for primary prevention of stroke, MI in those with normal kidney function. |
May26 |
FDA approves Samsca (tolvaptan) to treat hyponatremia. |
May25 |
Search all abstracts from the World Congress of Nephrology 2009 |
May22 |
New anti-inflammatory drug candidate works by releasing hydrogen sulfide gas. |
May22 |
Drinking from polycarbonate bottles for a week increases urinary bisphenol levels. |
May19 |
NF-kappaB inhibitor might be ideal drug to combat osteoporosis and periodontitis. |
May18 |
Edible vaccine against p24 protein of HIV elicits an antibody response in mice. |
May15 |
Interventional study in mice links cytomegalovirus infection to high blood pressure. |
May15 |
Metformin shown to act directly via CBP glucose-regulating protein in the liver. |
May14 |
Monotherapy with DARA, an endothelin and angiotensin I receptor antagonist, lowers BP a lot. |
May11 |
UMOD gene, associated with Tamm-Horsfall protein production, linked to kidney disease. |
May11 |
Cyclophilin may play a key role in arterial damage associated with atherosclerosis. |
May08 |
FDA approves generic version of mycophenolate mofetil |
May07 |
Calcimimetics inhibits late-stage cyst growth in an animal model of ADPKD. |
May05 |
Fresenius launches national retail pharmacy for dialysis patients. |
May01 |
Survey company releases report on usage trends for vitamin D, phosphate binders, and calcimimetics. |
Apr30 |
Januvia (sitagliptin) pancreatitis risk suggests potential drug class effect on the pancreas for GLP-1 enhancers. |
Apr27 |
Potential importance of vitamin D receptor, commensal bacteria, and olmesartan in autoimmune disease. |
Apr27 |
Biotech companies, including Baxter, scramble to respond to flu epidemic with vaccines. |
Apr26 |
Prostaglandin 2-alpha may be new target for control of blood pressure and atherosclerosis. |
Apr23 |
Bacteriophage used to successfully treat chronic Pseudomas ear infection |
Apr22 |
Alzheimer beta-amyloid can be degraded, and some drugs can increase breakdown rate 7-fold. |
Apr18 |
Ultrashort-acting prednisolone derivatives (antedrugs) stop inflammation and then are metabolized to avoid side effects. |
Apr17 |
New discoveries on how collagen activates platelets may lead to new treatments to prevent clotting. |
Apr16 |
Endothelin A receptor antagonist darusentan shows promising results in resistant hypertension. |
Apr16 |
Provenge prostate cancer vaccine significantly prolongs survival. |
Apr12 |
CXCL5, secreted by white adipose tissue, may be the link between obesity and inflammation and insulin resistance. |
Apr11 |
One thousand 2007-2009 audiofiles and slide/audio talks added to HDCN's 20 topic-related channels. |
A06 |
Impax, a generic drug manufacturer, challenged by Genzyme with Renvela patent. |
M30 |
Variants of nisin, an FDA-approved antibiotic used in food preservation, show effectiveness against MRSA. |
M30 |
FDA approves mTOR inhibitor everolimus for treatment of advanced kidney cancer. |
M29 |
Link to slide/audio and audio symposia on HDCN |
M25 |
Thymoquinone protects pancreatic beta cells from oxidative effects of protease inhibitors; a renoprotective role as well, maybe? |
M22 |
Protein in yellow peas lowers BP by 20% in animal model of PKD. |
M20 |
FDA panel gives nod to alternative to warfarin |
M18 |
Another statin (Crestor, rosuvastatin) fails to show a benefit (rumor has it) in dialysis patients. |
M17 |
Endothelial lipase linked to levels of good cholesterol |
M10 |
Bacteriophage-derived enzyme Cpl-1 better than amoxicillin in treating pneumococcal pneumonia. |
M09 |
Cranberry juice proanthocyanidins, and not low pH, impair E. Coli attachment to urinary bladder endothelium |
M04 |
FDA December, 2008 drug labeling changes (including Sensipar, CellCept, Actos) |
M04 |
Pharma consultancy of medical school faculty members in the news. |
M03 |
AMAG hopeful that the FDA will approve its injectable iron supplement. |
F27 |
FDA warns of tardive dyskinesia risk with Reglan (metoclopramide) |
F26 |
Clavulanate plus meropenem found to be surprisingy effective in vitro against multidrug-resistant TB |
F18 |
NEJM: Genetic testing helps predict warfarin dose. |
F18 |
Study suggests that warfarin dose needs to be lower in patients with CKD. |
F16 |
FDA approves Uloric (febuxostat) for treatment of gout. |
F12 |
FDA and consortium release first data on genetic associations with serious drug adverse events. |
F06 |
FDA approves antithrombin derived from the milk of genetically-modified goats. |
F05 |
Sensory nerves in fat cells help regulate lipolysis, according to animal study. |
F02 |
Leprosy drug clofazimine holds promise as an immunomodulatory agent. |
J31 |
FDA advisory panel recommends that Darvon (propoxyphene) be pulled from the marked due to suicide risk, low efficacy. |
J30 |
Epoxide hydrolase inhibitor reduces heart failure in animal model |
J28 |
Genzyme shares climb after Amgen abandons development of phosphate drug. |
J17 |
Kidney injury biomarker panel now commercially available for animal testing of new drugs |
J16 |
Mutations in gene regulating melatonin-mediated insulin secretion increases type 2 diabetes risk |
J15 |
New family of antibiotics isolated from hydras and leeches. |
J15 |
HipA, a protein kinase, involved in bacterial dormancy, allowing survival during antibiotic therapy. |
J10 |
FDA expert panel recommends approval of drug (antithrombin alfa) extracted from the milk of genetically-engineered goats. |
J09 |
New anti-anginal drug acts by working on sodium channels. |
J09 |
Human insulin produced by genetically modified safflower plants ready for testing. |
J08 |
Quest Diagnostics acknowledges errors (mostly overestimation) in vitamin D tests. |
D18 |
FDA raises the bar for new diabetes drugs |
N19 |
Did you know that your prescribing history is for sale? Fed appeals court supports NH law banning the practice. |
N19 |
FDA advisory panel greenlights anti-MRSA antibiotic telavancin, but not approved by the FDA yet. |
N18 |
New microRNA compound protects mice against heart failure. |
N18 |
Five days of cipro cause pervasive and persistent changes in gut microflora abundance. |
N14 |
Renal Week: Relative vitamin K2 deficiency linked to vascular calcification in ESRD |
N09 |
Rosuvastatin given to patients with normal cholesterol levels but high CRPs markedly lowers CV risk. |
N06 |
Ghrelin-like drug increases muscle mass by 20% in the elderly. |
N04 |
Strange, complex pharmacokinetics of methotrexate in RBCs have implications for clinical treatment. |
O29 |
Animal studies suggest potential benefits of drug holiday for patients taking sulfonylureas. |
O28 |
Topical treament for HSV cold sores achieves same results as oral systemic therapy. |
O28 |
Plavix (clopidogrel) may be inactivated by some calcium channel blockers. |
O27 |
Risks of irregular heartbeat and atrial fibrillation increased with fosamax and other bisphosphonates. |
O27 |
Pentoxifylline lowers proteinuria alone or in addition to an ACE inhibitor. |
O23 |
Hydrogen sulfide may be a key regulator of blood pressure. |
O23 |
European watchdog agency suggests not using diet drug rimonabant due to depression side effects. |
O17 |
FDA creates drug safety information webpages for patients and health professionals. |
O14 |
Resveratrol found in dark chocolate and cocoa. |
O14 |
Alpha-1-antitrypsin therapy expands beta-cell populations in the pancreas of mice with a model of type 1 diabetes. |
O13 |
A series of abstracts presented at CRF meeting suggesting that triple anti-platelet therapy (adding cilostatzol) improved outcomes. |
O07 |
Study illustrates importance of inflammatory macrophages in obesity; insulin resistance reversed by killing these cells. |
O07 |
One mechanism whereby ingestion of fatty foods (but not carbs or protein) can suppress hunger identified : OEA. |
O06 |
One-dollar-a-month polypill containing ASA, thiazide, ACEI, and statin to undergo clinical testing. |
O03 |
On Nov 3, U.S. Supreme Court to hear key product liability court regarding use of FDA-recommended drug labels. |
S26 |
Aptly named horny goat weed found to be a source of specific phosphodiesterase inhibitors. |
S25 |
Diabetic gastroparesis in mice reversed by restoring defective hemo oxygenase production. |
S22 |
Darapladib slows atherosclerosis in a pig model. |
S18 |
Are statins ineffective for protection against cardiovascular risks in women? |
S16 |
How should one properly dispose of unused drugs? No one seems to know. |
S16 |
Chamomile tea cuts diabetes complications (in rats) |
S16 |
Conbining thiazides with potassium-sparing diuretics markedly lowers cardiovascular mortality. |
S15 |
Carvedilol and alprenolol, but not other beta-blockers, stimulate cellular protective pathway in the heart. |
S14 |
Hospitals and nursing homes contribute to water contamination with pharmaceuticals through their disposal methods. |
S11 |
Rituximab prescribing info revised to reflect risk of progressive multifocal leukoencephalopathy. |
S10 |
Molecular mechanism of steroid-induced fatty liver determined. |
S10 |
Pentazocine shows encouraging results in a mouse model of diabetic retinopathy. |
S09 |
Serotonin transport receptor levels in the brain change with the seasons; may reflect seasonal affective disorder. |
S08 |
Once-a-week sustained release exenatide lowers HbA1c better than twice daily shots. |
S08 |
Genetic variants associated with markedly different vitamin B12 handling. |
S05 |
Bisphenol (present in polycarbonate plastics) linked to metabolic syndrome. |
S02 |
In vitro studies suggest role for antihistamine clemizole in treating hepatitis C |
S02 |
AJKD: Temporary iron depletion and relative thrombocytosis may underline increased mortality with high doses of EPO. |
A29 |
Singh and Furberg editorialize against use of thiazolidinediones due to CV risk and lack of CV benefit. |
A26 |
Allopurinol lowers blood pressure in hypertensive adolescents |
A26 |
Leptin injections keep rats with type 1 diabetes alive without insulin. |
A26 |
Twenty percent of Ayurvedic medicines found to be contaminated with lead, arsenic, or mercury. |
A22 |
Some evidence that Vytorin is, or maybe is not, associated with an increased cancer risk; FDA gets involved. |
A22 |
New antimicrobial approach tames, rather than kills, pathogenic bacteria, lowering risk of emerging resistant strains. |
A21 |
AMAG receives fast track designation from FDA for ferumoxytol as an MRI contrast agent. |
A20 |
Individual genome analysis shows that drug sensitivity may be poorly predicted by skin color (presumed race) |
A19 |
Effect of grapefruit juice on drug absorption and metabolism: new complexities |
A18 |
Researchers create milligram quantities of completely synthetic heparin |
A14 |
SpyCEP identified as key element to infectivity of group A strep associated with necrotizing fasciitis. |
A07 |
Bile acids play a role in glucose metabolism and insulin signaling. |
A01 |
FDA forces new labeling changes for ESAs under new law. |
J31 |
Two new drugs have profound effects on exercise conditioning in mice. |
J23 |
NEJM: Genetic mutation associated with most patients who develop myopathy on high-dose statins. |
J22 |
House Appropriations Subcommittee increases proposed FDA budget by more than 20% to over 2 billion dollars per year. |
J21 |
Anti-bacterial actions of cranberry juice explained by its action on fimbriae. |
J16 |
Doctors hopeful that improved blood thinners are on the horizon: Three new candidates. |
J13 |
Histone deacetylase (HDAC) inhibitor SAHA found to have anti-immune effects in graft vs. host disease. |
J11 |
FDA lists May 2008 labeling changes: Aranesp (tumor progression) and CellCept (lymphoma and PML risk) |
J10 |
Aspirin may benefit patients with osteoporosis: a possible mechanism identified. |
J10 |
Histone deactylase (HDAC) inhibitors protect ischemic tissue from injury. |
J09 |
Fresenius signs sublicensing agreement with Luitpold to use Venofer in United States patients. |
J08 |
Stanford researchers find molecule that kills kidney cancer cells, STF-62247. |
J08 |
FDA adds boxed warning on risk of tendon rupture associated with fluoroquinolone antibiotics. |
J07 |
Fresenius Medical buys heparin-maker APP pharmaceuticals. |
J03 |
Statins spur glial progenitor cells to develop into oligodendrocytes. |
J03 |
Pfizer will no longer work directly with for-profit CME companies. |
J03 |
FDA panel recommends that all new diabetes drugs be screened for cardiovascular risk. |
J02 |
New orally active, broad-spectrum angiogenesis inhibitor may be useful against many cancers. |
J28 |
Bill to approve pathway for FDA approvals of biosimilars advocated as saving billions of dollars. |
J26 |
Two siRNA in the Phase I/II pipeline for kidney disease, one for delayed graft function, the other for AKI |
J24 |
Take your meds and have a chance at winning the lottery. |
J23 |
Rapamycin may impact retardation in tuberous sclerosis and might be useful in treating autism. |
J19 |
FDA cautions about increased mortality in elderly patients with dementia who had been treated with antipsychotic drugs |
J18 |
Computer generated warfarin dosing as effective as dosing by expert prescribers. |
J13 |
FDA and EMEA to consider biomarkers of renal injury in animal studies evaluating renal safety of new drugs. |
J12 |
XBP1, stimulated by a high-carb diet, may be a new target for treatment of dyslipidemias. |
J12 |
FDA approves generic form of ramipril made by Lupin pharmaceuticals. |
J11 |
CMS gives researchers access to parts of the Medicare prescription drug benefit database. |
J05 |
FDA: More on the ongoing review of TNF-blockers and cancer risk. |
J05 |
Study in mice suggests resveratrol has marked cardioprotective effects. |
M23 |
FDA to use Medicare claims data to monitor drug side effects once drugs have been marketed. |
M19 |
Protein the mimics phagocyte defensins effective against resistant bacteria on in vitro testing. |
M18 |
New superdrug may be useful against MRSA superbugs. |
M17 |
FDA convenes to examine impact of direct-to-consumer pharmaceutical, and now, medical device, advertising. |
M13 |
Texting kids to take their medicine may increase compliance. |
M09 |
Darapladib lowers the activity of inflammatory enzyme associated with vascular plaque. |
M05 |
ASN Renal Week abstract archives 2003-2006 now available on-line in .pdf format. |
M02 |
New ACE 2 activator compounds lower blood pressure in rats and also reduce cardiac and renal fibrosis. |
A28 |
FDA approves Relistor (methylnaltrexone) for opioid-induced constipation. |
A25 |
First ever activator of ENAC sodium channel developed. |
A24 |
GAO says that FDA lacks resources to inspect non-US drug suppliers; only 8% are being inspected now. |
A23 |
Genzyme to build new research and development center in Beijing. |
A23 |
Some compounds in Chinese bitter melon identified with activity against diabetes. |
A22 |
CMS releases standards for e-prescribing of drugs. |
A21 |
Massachusetts Senate unanimously passes a law banning all pharma gifts to doctors. |
A19 |
Democrats propose labeling requirements for food and drugs which would list country of origin. |
A10 |
FDA notice regarding investigation of mycophenolate mofetil regarding progressive multifocal leukoencephalopathy. |
A07 |
New antimicrobial proteins identified in alligator blood |
A04 |
AMAG Pharma presents data on new iron supplement at NKF Spring Clinical Meeting. |
A03 |
New Merck heart failure drug rolofylline gives encouraging results in Phase III trial. |
M27 |
Keryx ends development of sulodexide after negative trial results. |
M19 |
Roche agrees to pay Amgen 22.5 percent royaty on Mircera sales in the U.S. |
M13 |
FDA Oncologic Drug Advisory Panel recommends continued indication of ESAs for cancer patients excluding breast and head and neck. |
M12 |
Keryx diabetes drug sulodexide fails to achieve primary endpoint in phase III clinical trial. |
M11 |
Eli Lilly follows Pfizer and NovoNordisk in discontinuing inhalable insulin. |
M10 |
FDA plans to ease restrictions on dissemination of reprints by pharma involving off-label usage of drugs. |
M07 |
Bill to encourage e-prescribing for Medicare-reimbursed encounters likely to pass this year. |
M06 |
More on the heparin contaminant in Baxter's product line - still unidentified. |
M05 |
Massachusetts may ban drug industry freebies for docs. |
M05 |
Supreme court votes 4 vs. 4 regarding pharma immunity from product liability for FDA-approved prescription drugs. |
M05 |
FDA finds possible contaminant in Baxter heparin. |
M05 |
Sensor necklace and magnetic trace additive to pills might be used to track medication compliance in clinical trials. |
F27 |
Supreme Court hears arguments as to whether pharma companies should be protected from torts when a drug has been approved by the FDA. |
F26 |
FDA: Medication guide must be given to patients with each rosiglitazone (Avandia) prescription. |
F20 |
AMAG submits NDA to FDA for ferumoxytol. |
F16 |
FDA issues draft guidelines for comment to Pharma about distributing reprints describing off-label usage of drugs. |
F16 |
Baxter heparin case calls attention to Chinese chemical companies supplying drug raw materials with minimal regulation. |
F16 |
Promising early data from another prostate cancer vaccine trial. |
F15 |
Some cholesterol synthesis inhibitors also block Staph. aureus pigment synthesis, rendering the germ less pathogenic. |
F07 |
FDA warns on adverse effects due to intravenous colchicine. |
F01 |
Anti-leishmaniasis drug miltefosine kills HIV-infected macrophages, eliminating one protected site of HIV persistence. |
J28 |
Vytorin lowers cholesterol, but does not impact on endpoints; House asks FDA to reconsidering hard vs. soft endpoints in proving drug value. |
J25 |
Cox-2 inhibitors can cause arrhythmias by affecting potassium channels in the heart. |
J16 |
FDA warns of name confusion between two edetate compounds used for chelation. |
J11 |
Gas6 protein may augment the action of erythropoietin |
J09 |
Cannabinoid receptor blocking drug effective in causing weight loss. |
J02 |
Labeling on adrenaline vials in terms of concentration are confusing, lead to errors. |
J02 |
European study could find no link between non-phenacetin pain killers and ESRD |
D27 |
FDA approves synthetic starch-based volume expander fluid. |
D27 |
New orally active cyanide antidotes discovered. |
D21 |
Animal study suggests that EPO may protect hearts against toxicity of anticancer drugs |
D20 |
FDA issues draft guidelines to industry for reporting adverse events linked to OTC drugs and dietary supplements. |
D19 |
Northwestern University gets 700 M royalties for diabetes pain drug patent. |
D19 |
AMAG pharma submits new drug application to FDA for ferumoxytol. |
D17 |
US House Rep Waxman leaks FDA planned guidance to OK drug company promotion of off-label uses of drugs. |
D17 |
Drug that stimulates thyroid hormone beta receptors effective in lowering LDL cholesterol |
D15 |
U.S. FDA considers allowing a new group of -behind the counter- drugs to be dispensed with pharmacist approval only. |
D14 |
FDA warns of serious adverse reactions with iron chelator Exjade. |
D08 |
FDA launches new drug safety newsletter. Here is the first issue (rituximab) |
D05 |
Dennis Quaid sues Baxter over label similarities between low- and high-dose heparin vials. |
D04 |
FDA approves study of iron-containing dialysate additive for hemodialysis patients. |
D03 |
Pharma companies to develop IgA proteases as a potential treatment for IgA nephropathy. |
D03 |
Topical cleaners containing benzethonium chloride bactericidal against MRSA. |
N27 |
FDA: Use of mycophenolate mofetil during pregnancy associated with increased risk of pregnancy loss and congenital malformations. |
N26 |
Nitrosyl cobamide shows promise as an NO-donor type of drug for hypertension or heart disease. |
N25 |
Executives from Genzyme and Johnson and Johnson to sit on FDA foundation board. |
N16 |
CMS pushing e-prescribing for Medicare beneficiaries. |
N16 |
Pramlintide-leptin combination drug induces 13% weight loss in obese patients. |
N15 |
FDA approves Roche ESA anemia drug Mircera |
N14 |
Cattle vaccine shown to be effective in lowering rate of toxigenic E. Coli carriage. |
N14 |
FDA adds black box warning of heart attacks for Avandia (rosiglitazone) |
N09 |
Placenta cloaks its proteins with phosphocholine (as do parasitic worms) to evade immune detection. |
N08 |
FDA modified boxed warnings, indications, for ESA drugs. |
N08 |
Skeletal muscle damage due to statins may operate through atrogin-1 and thus may be preventable. |
N06 |
Shire announces results of Fosrenol trial in stage 3-4 CKD patients. |
N05 |
New vascular function of hemoglobin, as a promoter of nitric oxide synthesis, identified. |
N01 |
Legislation introduced in the House to fight spread of drug-resistant bacteria. |
O29 |
Bacterial use peptides to communicate with each other: extracellular death factor identified. |
O25 |
Bayer issues additional guidance to physicians about Trasylol (aprotinin). |
O25 |
Genzyme launches cholesterol-binding drug (Cholestagel) in Europe for patients with primary hypercholesterolemia. |
O25 |
SQ109, promising anti-tuberculosis drug, given special status by European and U.S. regulators. |
O25 |
Genzyme profits increase tenfold on sales of drugs to treat rare diseases. |
O23 |
Acute pancreatitis associated with exenatide (Byetta) - FDA requires labeling change |
O19 |
Sudden hearing loss associated with erectile dysfunction drugs. |
O17 |
Vaprisol (conivaptan) study shows increase in serum sodium in euvolemic hyponatremia. |
O17 |
FDA advisory committee votes in favor of phosphate binder use for stage 4 CKD. |
O16 |
FDA approves Doribax(tm) - doripenem - for complicated urinary tract infections, including pyelonephritis |
O16 |
Velcade (bortezomib) for multiple myeloma now approved for use in patients with impaired renal function. |
O12 |
FDA advisory meeting next Tuesday to study use of phosphate binders in pre-ESRD - Genzyme, Shire, Fresenius will all be present. |
O12 |
Statins help preserve lung function during aging. |
O08 |
New antibiotic ceftobiprole very effective in curing diabetic foot infections. |
O03 |
Rockwell begins dosing patients with iron (soluble ferric pyrophosphate) - containing dialysate. |
S25 |
New, synthetic version of heparin is patented. |
S25 |
FDA to screen all direct-to-consumer (DTC) television ads if pending law is passed. |
S20 |
Rockwell begins enrollment into Phase IIIb trial of dialysate sodium ferric pyrophosphate for iron therapy. |
S11 |
Nabi to sell its Biologics division, and plans to move its headquarters. |
S06 |
FDA approves first generic versions of carvedilol (Coreg). |
A30 |
New mechanism of action of thiazolidinediones discovered. |
A21 |
Unlike grapefruit juice, pomegranate juice does not appear to affect cytochrome P450-3A activity |
A19 |
Bacteriophage treatments coming back into favor to combat superbugs such as MRSA. |
A17 |
Patients who develop kidney failure after use of phosphate-based laxatives initiate lawsuits. |
A17 |
FDA warning letter issued emphasizing pharmacogenomic variability in warfarin metabolism among patients. |
A08 |
Annals: New study questions the increased heart attack risk with Avandia; original NEJM meta-analysis claimed to have been flawed. |
A07 |
Publix supermarkets to offer up to 14-days of free antibiotics. |
J30 |
FDA Advisory Panel to explore safety and risks of Avandia. |
J24 |
Ferumoxytol Phase III clinical trial results achieve desired endpoints. |
J21 |
New Cochrane analysis focuses on increased side effects in patients taking rosiglitazone (Avandia) |
J19 |
Weight loss pill rimonabant associated with increased suicide risk. |
J16 |
Older, cheaper pills just fine to treat diabetes. |
J16 |
Affymax announces phase 3 development program for Hematide. |
J12 |
Hydroxychloroquine (Plaquenil) may be protective against developing type 2 diabetes. |
J09 |
FDA warning: precipitation when infusing ceftriaxone with calcium-containing solutions. |
J27 |
Amgen makes labeling changes for Sensipar - no longer labeled for use in pre-ESRD patients. |
J22 |
FDA approves pregabalin (Lyrica) for treatment of fibromyalgia. |
J22 |
FDA clears "computerized medication box" (EMMA) for U.S. market. |
J19 |
Randomization complete for phase III trial of sulodexide for diabetic nephropathy. |
M23 |
Diethylene glycol - contaminated toothpaste linked to source in China |
M23 |
Iron-chelating agent defasirox (Exjade) associated with acute renal failure. |
M03 |
NEJM: Drug risks and free speech - can Congress ban direct-to-consumer ads? |
A30 |
Compound from bullfrogs has marked anti-MRSA activity. |
A07 |
Arthritis patients with CVD who take ibuprofen plus aspirin may greatly increase their cardiac risk. |
M26 |
Tolvatptan improves signs and symptoms in patients with CHF. |
M26 |
Nesiritide safety trial shows neutral effect on mortality in CHF patients |
M22 |
FDA moves to limit participation of MDs with ties to pharma companies on its advisory boards. |
M12 |
Azole antifungal drugs found to be active against tuberculosis. |
M08 |
Indian pharma firm Biocon unveils suite of immunosuppressive drugs aimed at the transplant market. |
M06 |
FDA approves aliskiren for treatment of hypertension. |
M05 |
Taking amphotericin B in oil by mouth may result in good efficacy, less renal toxicity. |
M02 |
NEJM: Vancomycin-induced thrombocytopenia: the article link |
F28 |
NEJM: Immune-mediated thrombocytopenia linked to vancomycin use. |
F23 |
MMWR: Nephrogenic fibrosing dermopathy. |
F05 |
FDA approves new dosing recommendations for Rapamune (sirolimus) in high immunologic risk transplant patients. |
F01 |
Biotrends report of Dec 2006 survey on use of ESAs and phosphate binders. |
J16 |
DNA test to be used to determine warfarin dose. |
J15 |
House passes Medicare drug bill. |
J09 |
Two Wisconsin companies get together to develop ingested products for hyperphosphatemia control. |
J09 |
Potential bias in studies funded by the food industry or by pharma in the news. |
J04 |
Genzyme files new drug application with the FDA for sevelamer carbonate. |
J03 |
Renal Advantage completes acquisition of Renalab. |
D31 |
Gene knockout technology creates healthy, prion-protein-free cows |
D29 |
FDA evaluating safety of products from cloned animals; seeks outside comments. |
D28 |
Advanced Magnetics stock surges on hopes for ferumoxytol. |
D22 |
FDA announces that it is still evaluating a possible link between MRA with gadolinium and nephrogenic fibrosing dermopathy. |
D22 |
Multidrug resistant E. coli linked to antibiotic use on farms in the U.K. |
D21 |
Genzyme files for FDA approval of sevelamer carbonbate - Renvela. |
D20 |
FDA to require labeling changes for acetaminophen and for NSAIDs to highlight potential risks. |
D16 |
FDA updates labeling for Trasylol (aprotinin) regarding risk of renal dysfunction, anaphylaxis, and re-exposure. |
D12 |
Phase 3 trial shows Avastin (bevacizumab) improves progression-free survival in renal cancer patients. |
D12 |
FDA campaigns against use of quinine for conditions other than malaria; cautions against use of quinine for leg cramps. |
D11 |
FDA proposes rules overhaul to expand access to experimental drugs. |
N30 |
Dynavax stock rises on news of positive results for Hepatis B vaccine in difficult to immunize patients. |
N28 |
Genzyme researchers show promising results with drug against polycystic kidney disease. |
N26 |
HDCN: Search index updated for audiofiles, slide/audio talks, articles, and abstracts |
N18 |
CMS plans to open up physician-prescribing drug database to researchers |
N14 |
Nabi reaches deal with hedge fund on directors, chairman. |
N10 |
FDA approves pramipexole (Mirapex) for treatment of restless legs syndrome in nonuremics |
N10 |
FDA considers expanding patient access to experimental medications |
O30 |
Pharma supported patient education sites under the microscope. |
O26 |
Phase 3 trial design for belimumab to treat SLE approved by FDA |
O23 |
FDA approves once-a-day Coreg (carvedilol) CR for 3 cardiovascular indications |
O18 |
Cockcroft Gault equation (modified) better than MDRD for adjusting vancomycin dose in the elderly. |
O18 |
Rockwell submits dose ranging study for dialysis solution iron supplement to FDA |
O17 |
FDA approves new treatment for diabetets - Januvia (sitagliptin) |
O10 |
Biodegradable gel stops bleeding promptly |
S28 |
Amgen colon cancer drug gets FDA approval |
S28 |
Meditor working on development of intradialytic hypotension drug. |
S27 |
U.S. House and Senate pass bill allowing purchase of drugs from Canada |
S27 |
La Jolla Pharm announces addition of new sites, reactivation of Riquent (abetimus) study to treat lupus. |
S26 |
Generex develops metformin-containing chewing gum, oral insulin spray, as novel drug-release products. |
S19 |
FDA approves posoconazole to treat Aspergillus and Candida fungal infections. |
S18 |
Food and drugs pass through the stomach very quickly or quite slowly. |
S13 |
More bad news in JAMA paper about CV and kidney risks of COX-2 inhibitors and NSAIDS |
S12 |
New class of pain relievers may help, not hurt, the heart |
S11 |
Advanced Magnetic (ferumoxytol) hires Brenner, Salem, in top positions |
S11 |
Bacterial conversation stoppers may block formation of biofilm |
S11 |
Chitosan (from crabs and shrimp) found to block formation of biofilm. |
S11 |
Want to fight fat? Eat brown seaweed! |
S06 |
Advanced Magnetics completes enrollment for phase 3 trial of ferumoxytol IV iron. |
S06 |
Virtually untreatable type of tuberculosis being identified worldwide |
A24 |
FDA proposes system to systematically register and uniquely identify all drugs sold in the U.S. |
A19 |
Spray on bacteriophages approved to control Listeria on meat; toxigenic E. Coli next on the list. |
J31 |
Survey of FDA scientists documents political interference in drug approval process |
J24 |
Rockwell gearing up to study efficacy of dialysis solution-based iron therapy. |
J21 |
Fresenius to debut calcium-acetate / magnesium-carbonate phosphorus binder in Germany. |
J20 |
New antibiotic tygecycline available in the UK to treat MRSA. |
J10 |
Some drug metabolism / detoxification has a pronounced circadian rhythm. |
J02 |
Cytochroma acquires Proventiv Therapeutics to commercialize new Vitamin D products for CKD market |
J28 |
How to restrict access to your medication prescribing data |
J28 |
Did you know that drug companies have full access to your medication prescribing data? |
J20 |
ISMP and FDA issue medical abbreviation blacklist - QOD, IU, ug, qHS, all likely to cause errors (pdf) |
J07 |
Congenital malformations with first-trimester ACE-inhibitor therapy. |
J05 |
Isis Pharma gets orphan drug status for familial hypercholesterolemia drug. |
J02 |
Heart attack risk with COX-2 broadened to include most NSAIDs |
M17 |
Superbug slain by soil antibiotic |
M15 |
Aspirin may protect against gentamicin-induced hearing loss. |
M09 |
Getting rid of the furanocoumarins in grapefruit juice abolishes the juice's effects on CYP3A drug metabolism |
M01 |
Astellas acquires rights to two new orally-active prolyl hydroxylase inhibitor drugs to treat anemia. |
A26 |
GI hormone oxyntomodulin lowers appetite, increases activity level |
A26 |
FDA approves first generic pravastatin. |
A25 |
University of Michigan to pay for preventive diabetes meds for its employees. |
A21 |
Orally available iron chelating agent desafirox shows promising results. |
A20 |
Roche files with FDA for approval of its anemia drug CERA (continuous erythropoetin receptor activator) |
A19 |
FDA grants priority review to Neurochem for Fibrillex - AA amyloidosis drug. |
A13 |
FDA announces public meeting focusing on regulation of nanotechnology |
M21 |
Nabi to resume development of Staph. vaccine. |
M17 |
New vitamin D anticancer effects may be separable from its bone effects. |
M15 |
Six men in monoclonal antibody drug trial critically ill. |
M12 |
Losartan metabolite activates PPAR-gamma |
M09 |
Nabi's NicVax (smoking cessation vaccine) given fast-track status by US FDA. |
M06 |
Annals: Dramatic recent rise in community-acquired MRSA infections. |
M03 |
Serotonin may play a role in hardening of the arteries. |
M02 |
Hyperglycemia and hypoglycemia associated with use of gatifloxacin. |
F24 |
FDA approves new antifungal drug (Eraxis) effective against serious Candida infections. |
F24 |
Tolvaptan receives FDA fast-track approval status to treat polycystic kidney disease. |
F21 |
Is there a way to avoid the bladder toxicity of cyclophosphamide? |
F21 |
Alginate-encapsulated pancreatic islet cell transplants for diabetes. |
F13 |
Neurochem submits Fibrillex to the FDA for control of AA amyloidosis |
F06 |
Synthetic heparin could replace animal-derived drug. |
F01 |
Nabi announces fast tracking of hepatitis C immune globulin by the FDA to prevent HCV reinfection. |
J28 |
Baxter mourns death of William Graham, pioneer and leader in healthcare. |
J28 |
FDA approves first ever inhaled insulin for the treatment of diabetes. |
J26 |
FDA approves Sutent - new angiostatin treatment for metastatic kidney or stomach cancer. |
J26 |
Aprotinin (Trasylol) linked to increased risk of kidney failure, heart attack and stroke. |
J24 |
Alagebrium (a collagen cross-link breaker) softens arteries - and that's good for you. |
J24 |
Archives: Chronic warfarin use increases risk of bone fracture. |
J23 |
Annals: Liver failure and hepatitis from telithromycin. |
J22 |
AHA review casts doubt on cardiovascular health benefits of soy-based foods. |
J21 |
British study shows that work stress linked to both heart disease and metabolic syndrome. |
J21 |
Medicare Part D changeover leaves some Florida patients without payments for transport to dialysis. |
J19 |
New drug label rule intended to reduce medical errors. |
J19 |
Study of drug resistance among bacteria found in soil can potentially guide new drug development. |
J19 |
Commonly used antidepressants may also affect the immune system. |
J19 |
MMWR: Type A influenza highly resistant to amantadine derivatives |
J18 |
Rockwell Medical Technologies gets rights to market vitamin- and carnitine-supplemented dialysate. |
J17 |
Anti-obesity drug from cannabis really works? |
J16 |
Canadian study suggests higher mortality among diabetics treated with sulfonylurea drugs vs. metformin. |
J15 |
Acetazolamide reduces sleep apnea severity in heart failure patients. |
J15 |
Hypothalamus has a fatty acid sensor that may regulate food intake |
J07 |
CJASN: Diagnostic and Therapeutic Corner: HAART and the Kidney |
J07 |
Brain protein (p11) may play a critical role in depression. |
J06 |
Post-marketing data detects new onset / worsening of macular edema in patients taking Avandia (rosiglitazone). |
J05 |
MRSA patterns in ICUs changing: 64% prevalence rate, hardier, bugs, but less multi-drug resistance. |
J04 |
FDA approves conivaptan (Varprisol) for treatment of euvolemic hyponatremia in hospitalized patients. |
J04 |
Adenosine receptor antagonist completes phase 2 trials for congestive heart failure. |
D27 |
Acetaminophen can cause acute liver failure when usual dose is even slightly exceeded. |
D26 |
Dalbavancin (a vancomycin-like drug) effective in mice against anthrax. |
D17 |
Heteropolymer antibodies - a new approach to treat and prevent? MRSA infections. |
D17 |
CDC recommends new blood test to diagnose TB infection. |
D14 |
Amgen buys Abgenix, maker of panitumumab (colon cancer drug). |
D12 |
Oral endothelial receptor antagonist ambrisentan effective in pulmonary HTN. |
D11 |
Pramexipole for restless legs syndrome in nonuremics. |
D10 |
Encyclopedia of traditional Indian medical knowledge to be on the internet. |
D03 |
Random testing shows high lead levels in some imported Chinese plums. |
N28 |
Higher dose of Fosrenol (lanthanum carbonate) approved by FDA for ESRD patients. |
N17 |
Oralyn, an oral insulin-like drug, to be launched this month in Ecuador. |
N17 |
Tea, cinnamon, buckwheat, and cherries for diabetics. |
N17 |
AHA: CV mortality benefits of diuretics linked to alpha-adducin genotype. |
N16 |
AHA: Aliskiren (renin inhibitor) adds to anti-HTN effects of irbesartan. |
N12 |
Risk-stratified analysis proposed to analyze RCTs to detect harm. |
N07 |
AAKP info sheets on Medicare Part D drug benefit for kidney patients. |
N06 |
More on the new FDA digital drug label submission requirement. |
N06 |
New FDA-supported website lists latest approved drug labels for all meds. |
O30 |
Making sense of the new Medicare Part D drug plan. |
O28 |
FDA delays decision on approving inhalable insulin |
O27 |
New endogenous carbohydrate (INS2) discovered that lowers blood glucose. |
O26 |
ASN Renal Week 2005 abstracts now available on-line. |
O24 |
Shire highlights publication of 1 and 3-year Fosrenol extension study. |
O20 |
Tigecycline may offer promise to treat MRSA and vancomycin-resistant bacteria. |
O18 |
RPA compiles info on Medicare D drug benefit plan on its website. |
O12 |
New defensin-class antibiotic isolated from pine forest fungus. |
O05 |
Generic form of amlodipine approved by the FDA |
S29 |
JASN: Acute phosphate nephropathy following certain bowel preps. |
S28 |
Toprol (metoprolol)/Topamax/Tegretrol look-alike names prompt FDA alert letter. |
S28 |
Nabi sues Ohio company for patent infringement over generic calcium acetate. |
S26 |
Genzyme could see upside if Renagel included in Medicare Part D. |
S25 |
Genes on chromosome 2 linked to resistant hypertension. |
S22 |
Affymax launches phase 2 study of NESA to treat anemia in European CKD patients. |
S22 |
Pharma organization launches global clinical trials database. |
S21 |
Nabi launches study to see if StaphVax will protect dialysis patients long-term. |
S20 |
Novartis oral renin inhibitor aliskiren shows good results in phase III trial. |
S13 |
Pioglitzaone improves cardiovascular outcomes in diabetics. |
S11 |
FDA approves first glitizar-class drug for treatment of type 2 diabetes. |
S09 |
FDA advisory panel recommends approval of inhaled insulin. |
A28 |
Medicate part D to help cover costs for kidney patient drugs. |
A25 |
Ten Canadian pharmacies apply for license to sell Rx drugs in Nevada. |
A22 |
Scios announces recommended use initiative for Natrecor. |
A22 |
Long-acting form of exenatide works in type 2 DM; Amylin shares soar. |
A19 |
Jury awards widow 253 million in Vioxx suit against Merck. |
A19 |
Magnetic nanoparticle MRI used to visualize inflammed pancreas in type 1 DM. |
A19 |
Myogen announces phase 2 trial results of darusentan in resistant hypertension. |
A19 |
Novartis trying to develop alternative phosphate binding drug. |
A18 |
Will FDA approve diabetes-related health claims for chromium picolinate? |
A16 |
Do clinical trial docs leak info about new drugs to stock brokers? |
A16 |
Analgesic drug use linked to high blood pressure in women. |
A16 |
Kidney Drug Coverage website: Teleconference schedule |
A11 |
Following clinical guidelines in elderly can lead to polypharmacy. |
A11 |
Pfizer files for FDA approval of new renal cancer drug Sutent. |
A02 |
Op-Ed piece suggests the FDA should loosen up; allow patient to choose some risk |
J28 |
Drug dose adjustment in CKD: Guru texts may not agree. |
J28 |
FDA bans use of Bayer fluoroquinolone in poultry to fight rise in superbugs. |
J23 |
Is your clinical trial registered? If not, you may not get it published! |
J22 |
Nabi initiates phase 1 trial of vaccine against another strain of S. aureus. |
J22 |
Retinol-binding protein implicated in obesity, insulin resistance. |
J19 |
Reductions in Medicare payments for IVIG lead to problems: Portent for EPO? |
J19 |
Annals: If Medicare were to provide ACE-I for free, it would be cost effective. |
J19 |
Natrecor (nesiritide) safety summary (Scios) |
J14 |
NIH finds ethics violations by its employees in 44 cases. |
J14 |
NEJM op-ed piece attacks continued use of nesiritide. |
J14 |
New super-EPO (PT-401) drug under development. |
J14 |
Genzyme on a roll - good financial results, drugs in the pipeline. |
J13 |
Nabi says Staph vaccine ups immunity. |
J11 |
Q-med gets funding to further develop Ixion's oxalate technology. |
J11 |
Carotenoids give gold color to S. aureus, and protect it from oxidation by WBCs. |
J08 |
Genomic mechanism of increased azathioprine toxicity identified. |
J07 |
Phase 3 trial begins of endothelin A receptor antagonist in diabetic nephropathy |
J06 |
House bill to mandate reporting of all pharma clinical trials in registry. |
J06 |
Law introduced to help prevent counterfeit drugs, especially EPO. |
J06 |
Growth hormone releasing factor may prevent malnutrition in stage IV CKD. |
J04 |
Medlearn matters (SE0541) Medicare Prescription Drug Coverage |
J30 |
Canadian Health Minister to restrict U.S. access to Canadian meds. |
J29 |
Consumer reports announces "best buy" calciuim channel blockers. |
J29 |
Keryx initiates phase 4 study of sulodexide to treat diabetic nephropathy. |
J28 |
Pfizer review claims no link between Viagra use and blindness. |
J27 |
Will a next-generation HBV vaccine be more effective? Trial in progress. |
J27 |
Omiganan topical antibiotic designed to prevent central venous catheter infxns. |
J24 |
Canada aims to curb internet drug trade. |
J18 |
Acologix and Toray team up to commercialize uremic itching drug. |
J14 |
Large multinational study shows restless legs syndrome common in nonuremics. |
J04 |
Editorials, opinions (via Kaiser) on disclosing results of clinical trials. |
J03 |
Kaiser electronic med system reduces medication errors in CKD patients. |
M27 |
FDA investigating causes of blindness in users of Viagra/Cialis. |
M26 |
Deep sea bacteria may provide new tools to kill MRSA. |
M24 |
Crestor (rosuvastatin) associated with higher adverse event risk. |
M20 |
Nabi ramping up large scale production of its Staph vaccine. |
M19 |
New way of fighting antibiotic resistance - by blocking evolution in E. Coli. |
M13 |
Naturally occurring nanovaults eyed as vehicles to deliver gene/tumor therapy. |
M12 |
Neurochem to plead its case before the FDA for Fibrillex approval. |
M09 |
Two studies document the rise of superbugs in the environment. |
M05 |
Pollen, leaves from lilies cause acute renal and liver failure in cats. |
M03 |
Consumer Reports website suggest Best Buys for ACE inhibitors. |
M01 |
Sen. Frist explores idea of a ban on direct to consumer pharma advertising. |
A27 |
Combo Vytorin (ezetimibe + simvastatin) lower CHO better than atorvastatin alone |
A27 |
Indirect evidence that NSAIDS may prevent age-related macular degeneration. |
A21 |
Shire to acquire Transkaryotic - gets into anemia market with DYNEPO. |
A20 |
Nesiritide associated with an increased death rate in CHF patients. |
A19 |
Neurochem announces preliminary results on Fibrillex for AA amyloidosis. |
A18 |
Tougher CME conflict of interest rules take effect. |
A18 |
Melbourne researchers develop safer and more effective "aspirin". |
A13 |
Bugs in the gut could help doctors develop individualised healthcare |
A07 |
Pfizer suspends sales of COX-2 inhibitor Bextra at the request of the FDA. |
A07 |
FDA issues new rulings on NSAIDs - remove some, black box warnings for others. |
A05 |
Genzyme launches phase 3 study of tolevamer to treat C. difficile |
A01 |
Best buy recommends best value beta-blockers. |
M21 |
Nesiritide associated with risk of reduced kidney function in CHF patients. |
M18 |
Potential anti-prostate cancer effects of celecoxib. |
M17 |
FDA approves Symlin to help manage diabetes. |
M05 |
Pfizer working on new drug that raises HDL cholesterol. |
M04 |
Curis issued patent for use of BMP-7 to treat CKD. |
M02 |
FDA posts warning: Reduce starting dose of Crestor in Asians. |
F21 |
Big three automakers launch e-prescribing initiative. |
F17 |
Vitamin D may ward off prostate cancer. |
F15 |
Teva announces US launch of recombinant growth hormone for short-stature kids. |
F15 |
Hepatitis B vaccine administered orally via potatoes. |
F15 |
US FDA to create an independent drug safety monitoring board. |
F11 |
Meta chip provides quick, effective toxicity screen for new drugs |
F11 |
Progress toward new remedy for chronic urinary tract infections. |
F03 |
Another lanthanum-based phosphate binder in development. |
F03 |
Microdosing used to study pharmacokinetics of new renin inhibitors. |
J25 |
In retrospect, Vioxx may have caused many heart disease deaths. |
J24 |
Amgen involved with new stem cell company, ViaCell, with IPO today. |
J20 |
Merck threatens to cut off supply to Canadian pharmacies that sell to U.S. |
J20 |
NEJM: Aspirin/esomeprazole better than clopidogrel for CV risk prevention. |
J19 |
Amgen's next blockbuster drug - for osteoporosis. |
J17 |
Data entry is top cause of medication errors. |
J17 |
FDA requires handout be given to patients receiving amiodarone. |
J17 |
Drfug reimportation faces new hurdles. |
J15 |
FDA public meeting on COX-2 safety set for Feb 16-18 |
J15 |
FDA panel rejects OTC sale of statin drug made by Merck |
J13 |
Advanced Magnetics initiates large-scale trial of ferumoxytol IV iron. |
J11 |
Death in patient taking Crestor who had rhabdomyolysis. |
J11 |
NIH implements royalty disclosure policy among its staff. |
J10 |
NABI: Staph. aureus immune globulin treated patients leave hospital sooner. |
J06 |
Pharmacy prescription errors increase at the start of each month. |
J06 |
Canada considers shutting down internet drug trade. |
J06 |
Publication bias in the news - leads to incorrect regulatory decisions. |
J04 |
Long-term NSAID use linked to small intestinal damage, bleeding. |
D28 |
Voriconazole gets FDA approval for treatment of Candidemia. |
D23 |
FDA clears genetic test for cytochrome P450 variants involved in drug metabolism |
D23 |
Teva pharma reacquires marketing rights to IV calcitriol in the U.S. |
D22 |
Aspirin underused by people with diabetes. |
D22 |
Pharma industry awaiting Michael Moore's new documentary film with trepidation. |
D21 |
Nabi Pharma requests European regulatory approval for its StaphVAX product. |
D21 |
Naproxen linked to increased risk of heart attack,stroke |
D19 |
Consumer Reports: How to save money on buying statins. |
D19 |
Consumer reports BEST BUY website now operational |
D04 |
Gene identified that makes biofilm bacteria hibernate and evade antibiotics. |
D02 |
Consumer Reports to launch BEST BUY prescription drug price comparison website. |
N26 |
WHO warns of bird flu and possible upcoming flu pandemic. |
N24 |
Carbonic anhydrase inhibition linked to retinitis pigmentosa |
N10 |
Pfizer COX-2 inhibitor also doubles risk of heart complications |
N07 |
U.S. FDA to focus more on safety of marketed drugs |
N05 |
Mutant mushrooms trigger brain disease in Japanese dialysis patients |
O24 |
New TB vaccine shown to be safe |
O24 |
More on the Japanese dialysis patients with mushroom-associated illness |
O22 |
Japanese CKD patients become ill after eating apparently non-poisonous mushrooms |
O14 |
Nightline on ABC covers drug reimportation: video of Frist vs. Stabenow |
O14 |
AAKP requests open formulary for kidney patients without restrictions |
O10 |
Massachusetts e-health network to go live in 2005 |
O06 |
Bugs in the gut can influence the body's response to disease |
O06 |
One in six chronically ill adults skips Rx due to cost |
O05 |
Pyridostigmine effective in combatting orthostatic hypotension |
O02 |
Miniature swimming robot might be used for drug delivery |
S30 |
FDA comments on voluntary Vioxx withdrawal |
S30 |
Merck recalls Vioxx (rofecoxib) worldwide over concerns of increased CV risk |
S20 |
Progress made on drug trial registry |
S20 |
New British Approved Names (BANs) for generic drugs |
S12 |
Company making fake urine for research |
A21 |
Vermont sues FDA over block of Canadian drug imports |
A18 |
Illinois governor announces extensive prescription drug reimportation program |
A17 |
Newspaper examines industry bias in reporting sponsored trial results |
J26 |
Pharmacy benefit managers a growing force in Medicare |
J13 |
New and old ways to get lead poisoning: dinner plates and Ayurvedic medicine |
J07 |
Methotrexate use in dialysis patient may have led to patient's death |
J28 |
NY Times investigates drug company payments for prescribing interferon for HCV |
J25 |
U.S. consumer group argues that Crestor (rosuvastatin) is unsafe |
M01 |
Medicare Prescription Drug Assistance Program website |
M26 |
Packaging for Na/K too similar; needs to be differentiated |
M20 |
Labeling similarity of Baxter sodium, potassium products
questioned in Calgary |
M20 |
Calgary pharmacy potassium-sodium mixup happened before |
J09 |
Story on Genzyme and its plans for future products |
N26 |
FDA labeling change for lovastatin re myopathy / liver function |
N26 |
FDA labeling change for simvastatin re myopathy / rhabdomyolysis |
O21 |
FDA medwatch safety labeling changes (incl. lisinopril, enoxaparin) |
O19 |
US prescription drug system under attack |
O17 |
AJM: Drug promotion, rather than study publication, influences usage patterns |
J06 |
Astoundingly high levels of mercury found in whale organs |
D04 |
Red wine consumption interferes with cyclosporin availability |
O29 |
Corey Nahman Pharmacy News |